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5Prologue
Our  world  is  a  three-dimensional  space.  Thus,  all  molecules,  including  proteins,
have  three-dimensional  structures.  We  change  as  time  passes.  Thus,  the  structures  of
all  molecules  also  change  with  time.  Therefore,  my  ultimate  goal  is  to  elucidate  how
biological  molecules  change  their  structure.
Foreword
1.  Molecular  interactions  and  chemical  reactions
All  life  can  be  explained  in  terms  of  physical  and  chemical  machines,  so  it  is
important  to  understand  the  mechanisms  of  biological  reactions  from  physical  and
chemical  perspectives.  Biological  reactions  are  broadly  classified  into  "molecular
interactions"  and  "chemical  reactions".
A  "molecular  interaction"  is  a  non-covalent  association  of  two  or  more  molecules,
that  induces  conformational  changes  in  those  molecules  and  in  subsequent  reactions.
Their  importance  is  explained  by  the  following  examples:  Interactions  between  DNA-
binding  domains  and  DNA  have  been  reported  to  be  essential  for  all  nuclear  reactions
on  DNA,  including  transcription,  replication,  repair  and  recombination.  Similarly,
interactions  between  transcriptional  activation  domains  and  transcriptional  machinery
are  known  to  play  central  roles  in  transcriptional  activation.  In  signaling  cascades,  G
proteins,  kinases  and  other  signal  proteins  associate  with  cytosolic  domains  of  receptors
and  activate  downstream  signals.  Various  extracellular  ligands  associate  with
6receptors  on  the  cell  surface  and  activate  them.  Cell-cell  interactions  through  cell
adhesion  molecules  are  related  to  growth  and  differentiation.  These  phenomena  are
the  basis  of  life.
"Chemical  reactions"  include  all  enzymatic  reactions.  Examples  include  (but  are
not restricted  to),  synthesis,  degradation  and  metabolism  of nucleic  acids, protein,  lipid,
sugar  and  other  biological  molecules;  modification  (acetylation,  methylation,
phosphorylation,  ubiquitination  etc.) of histones  and  other proteins;  the  TCA cycle;  and
the  electron  transfer  system.  The  importance  of  these  reactions  for  life  is  beyond
dispute.
2.  Conformational  changes
Both molecular interactions and chemical reactions induce conformational changes
of proteins.  For example, the general transcription factor TFIID has been reported to
interact with transcriptional activators and to change its conformation on the promoter
DNA (1-3).  These conformational changes induce sequential molecular interactions
and chemical reactions.  Conformational change of proteins is purported to serve as a
"molecular  switch"  for initiating a  cascade of molecular reactions.  Therefore, it is
imperative to investigate the mechanisms underlying protein conformational changes.
This phenomenon  is mainly mediated by the rotation of the major peptide chains via
one of two mechanisms.  Firstly, rotation of the bond between C alpha and C or N in
the peptide bond occurs in all amino acids in their hinges or loops and is a continuous
form of rotation. Alternatively, cis/trans isomerization of the peptidyl prolyl imide-bond
can  occur, this  is  a  discontinuous  rotation  event  with  only  the  only  two  opposing
7directions  permitted  (4).  Thus,  in my  opinion  this  latter  mechanism  is well  suited  to
serving as a switching  mechanism  between  "ON"  and  "OFF"  in biological  reactions.
Many  biological  molecules  form complexes  in vivo.  Thus,  structural  change in the
formation  of macromolecular  complexes  (protein,  DNA,  RNA,  sugar,  lipid etc.)  is also
pivotal  for biological  reactions.  Structural  changes  of complexes  include  variations  in
the  association  and  dissociation  of  their  components.  Thus,  the  associations  and
dissociations  of macromolecular  complexes  are the central  theme  of this thesis.
3.  Alteration  of  chromatin  structure
DNA,  which  codes  genetic  information,  forms  condensed  structures  in  cells-
termed  "chromatin"-with  histones  and  other  chromatin  proteins.  Various  nuclear
reactions,  including  DNA  transcription,  replication,  repair  and  recombination,  induce
dynamic  alteration  in chromatin  structures.  In the alteration  of chromatin  structure,  the
structure  of  the  components  of  chromatin,  such  as  DNA  and  protein,  must  undergo
change.  In nuclear  reactions,  "ON"  and  "OFF"  must be clearly  distinguished.  On the
basis  of these  combined  observations,  I speculated  that PPIase  should play  a role  in the
alteration  of  chromatin.  Therefore,  I  have  started  to  investigate  the  importance  of
nuclear  PPIases  for chromatin  organization.(Introduction  figures  1 & 2)
To  discover  a  novel  mechanism  of  gene  expression,  it  is  essential  to  identify
previously  unknown  factors,  domains  or  enzymes.  Here,  I report  that  nuclear  FKBP
(FK506-binding  protein),  one of the PPIases,  is a novel  chromatin-modulating  factor.  I
8demonstrate  that  nuclear  FKBP  is  a  dual  functional  protein  comprising  histone
chaperone  and  PPIase  activities.  I also  show  that nuclear  FKBP participates  in rDNA
silencing,  which  is  involved  in  aging.  These  findings  shed  new  light  on  chromatin
analysis  and  suggest  a  link  between  alteration  of  nucleosome  structure  and
isomerization  of prolyl  bonds.  (Introduction  figures  1 & 2)
4.  Thesis  outline
This  thesis  describes  how  nuclear  FK506  binding  protein  (FKBP)  has two  distinct
activities  that mediate  structural  changes.
In the  1st section,  I will  report  the  isolation  and  characterization  of a  new nuclear
FKBP.  The  Schizosaccharomyces  pombe  (S.  pombe)  gene,  fkp39+,  that  encodes  a
homologue  of FKBP  (FK506  binding  protein)-type  peptidyl  prolyl  cis/trans  isomerase
(PPIase),  was  isolated  and  its  primary  structure  was  determined.  This  gene  product
(SpFkbp39p)  shows  PPIase  enzymatic  activity  in  a  chymotrypsin-dependent  enzyme
assay.  Comparison  of the primary  structures  of catalytic  domains  of FKBPs,  including
SpFkbp39p,  indicated  that  FKBPs  could  be classified  mainly  into four  groups.  Here, I
report  that this categorization  corresponds  to known  subcellular  localizations  of FKBPs,
suggesting  that  the  subcellular  localization  of  FKBPs  may  be  predicted  from  their
primary  structures.  On  the basis  of this  categorization,  SpFkbp39p  was  suggested  to
be  a member  of the  nuclear-type  FKBP  group.  Subcellular  localization  of HA-epitope-
tagged  SpFkbp39p  by  immunofluoresence  assay  indicated  that  SpFkbp39p  is localized
to  the  nucleus,  in agreement  with  my  prediction.  I also  identified  residues  which  are
conserved  in  a  "group-specific"  manner  in  the  catalytic  domain,  mapped  them  to
9corresponding  three-dimensional  positions  and  found  that  several  "group-specific"
residues  are  closely  aligned  in  distinct  regions,  mainly  on  the  protein  surface,  thereby
implying  the  presence  of  "group-specific"  regulatory  functional  regions.  I  also  found
that  nuclear-type  FKBPs,  including  SpFkbp39p,  possess  two  highly  conserved  domains
other  than  the  catalytic  domains,  in  addition  to  basic  and  acidic  charged  regions.
These  characteristics  are  specific  for  nuclear-type  FKBPs.
In  the  2nd  section,  I  demonstrate  the  activities  of  nuclear  FKBP  towards
chromatin.  Alteration  of chromatin  structure  is controlled  by the  concerted  actions  of
several  sets  of enzymes  and  factors.  These  proteins  include  histone  chaperones,  ATP-
dependent  chromatin  remodeling  factors,  and  enzymes  that  covalently  modify
chromatin  proteins,  such  as  histone  acetyltransferases  and  deacetylases.  Here,  I
describe  that  a  nuclear  FK506  binding  protein  (FKBP),  one  of  the  peptidyl  prolyl
cis/trans  isomerases  (PPIases)  originally  identified  as enzymes  that assist  in the proper
folding  of polypeptides,  possesses  histone  chaperone  activity.  This  histone  chaperone
activity  resides  in the N-terminal  region  of the protein  and is clearly  distinct  from  the C-
terminal  PPIase  domain.  Analyses  of null mutants  of nuclear  FKBP  genes  indicate  that
endogenous  nuclear  FKBPs  are  required  to  regulate  silencing  of  gene  expression  and
alteration  of the  chromatin  structure  at the rDNA  locus.  The N-terminal  domain  alone
can  function  in  chromatin  organization  in  yeast  cells.  These  in  vitro  and  in  vivo
observations  demonstrate  that  nuclear  FKBPs  represent  a  novel  type  of  chromatin
modulating  factor.
105.  Brief  overview  of  PPIases
1.  Identification  of  PPIases
Folded  proteins  contain  cis-prolines  while  newly  translated  proteins  only  contain
trans-prolines.  This  suggests  the  existence  of  an  enzyme  that  isomerizes  the
cis/trans  proline  transition.  Based  on  this  prediction,  enzymes  which  catalyze  this
reaction  have  been  identified  and  purified.  Determination  of the  primary  structure
of  these  enzymes  (peptidyl  prolyl  cis/trans  isomerase  (PPIase))  demonstrated  that
PPIases  are  the  same  enzymes  as  immunophilins  (cyclophilin  and  FKBP).
(Introduction  figure  1)
2.  PPIase  families
PPIases  are  classified  into  three  families  on  the  basis  of  their  primary  structures  and
known  inhibitors.  The  FKBP  family  binds  to  FK506,  whereas  the  cyclophilin
family  binds  to  cyclosporin  A  and  PIN1  does  not  bind  to  either.  Thus,  the  specificities
of  these  PPI  families  are  distinct  from  each  other.
3.  Relevance  of  focusing  on  PPIases
I here  isolated  chromatin  factors  by  a  two-hybrid  system  using  general  transcription
factors  as  baits.  FKBP  was  isolated  because  it  interacted  with  CCG1,  the  largest
11subunit  of  TFIID.  Since  both  the  structures  of  FKBP  and  TFIID  are  highly
conserved,  it  is  reasonable  that  they  should  interact  with  each  other.  This  prompted
me  to  study  the  influence  of  FKBP  on  chromatin  factors.
12Chapter  One
Isolation  and  initial  analyses  of  nuclear  FKBP-type  PPIases
1.1  Introduction
Conformational  changes  of  proteins  frequently  affect  protein-protein
interactions,  which  play  crucial  roles  in  controlling  the  qualitative  state  of  protein
function.  The  peptidyl  prolyl  cis-trans  isomerase  (PPIase)  may  induce  a
conformational  change  in proteins  in vivo  because  it catalyzes  interconversion  of  cis-
and trans-  isomers  of peptidyl-prolyl  bonds  in peptide  and protein  substrates  in vitro  (1,
2).  PPIase  is present  in  both  prokaryotes  and  eukaryotes  and  primary  structures  of
their  catalytic  domains  are highly conserved  (3).  PPIases  are thought  to be involved  in
protein  folding  (4) because  these  enzymes  accelerate  the refolding  of denatured  proteins
in  vitro  (5-7).  On  the  other  hand,  interactions  of  PPIases  with  specific  molecules
suggest  that  PPIases  may  have  other  functions.  For example,  FK506  binding  proteins
(FKBPs),  submembers  of the  PPIase  family,  have  been  shown  to interact  with  various
factors  (e.g.  FKBP12  interacts  with  TGF_  type  I  receptor  (8)  and  transcription  factor
YY1  (9), FKBP52  (also known  as p59, FKBP59,  HSP56  or HBI) with  steroid  receptors
(10-12),  FKBP25  with  casein  kinase  II  and  nucleolin  (13)).  Interactions  between
FKBPs  and  specific  target  molecules  affect  the  functional  state  of  their  targets,  in
13several  cases  (9,  14).  Recent  genetic  analysis  using  multi-cellular  organisms  revealed
that FKBPs  is involved  in biological  phenomena  such as development  (15-17).
PPIases  can be classified  into three  subfamilies  on the basis  of differences  in sensitivity
to  potent  inhibitors,  the  FKBP,  cyclophilin  (CyP)  and  parvulin  families,  respectively.
FK-506  and  cyclosporin  A  selectively  bind  FKBPs  and  CyPs,  respectively,  and  inhibit
PPIase  activities  (18-21),  whereas  the parvulin  family  is insensitive  to these  drugs  (22).
The  primary  structures  of the  catalytic  domains  are  similar  to  each  other  within  the
subfamily  members  but differ among  the three  subfamilies.  Moreover,  comparisons  of
the  tertiary  structure  of  each  protein  revealed  that  similar  residues  among  primary
structures  in each  subfamily  are  also  limited  by  a three-dimensional  structure  (23).  In
eukaryotic  cells,  PPIases  are  localized  in  various  cellular  compartments  (21).  In
S.  cerevisiae,  there  are four  FKBPs  (24-29),  eight  cyclophilins  (29-36)  and  one parvulin
(22,  37),  and  that  three  PPIases  are  localized  in the  cytoplasm  (Fpr1,  Cpr1,  6),  four  in
the  ER (Fpr2,  Cpr2,  4, 5), one  in the mitochondria  (Cpr3)  and two  in the nucleus  (Fpr3,
Essl)(22,  29),  suggesting  that  functional  targets of PPIase  might be diversified.
To  elucidate  functional  roles  of PPIase  in  each  cellular  compartment,  but
particularly  in the nucleus,  we isolated  a nuclear-type  PPIase  from  S.  pombe,  a favorable
model  organism  to  analyze  biological  function  both  biochemically  and  genetically.
Clues to understanding  the universal  molecular  mechanisms  between  mono-and  multi-
cellular  organisms  may  be  found  in  S.  pombe  because  molecular  mechanisms  of  the
several  biological  phenomena  in S.  pombe  are more  analogous  to those  in multicellular
organisms  than  those  in  S.  cerevisiae,  in  several  aspects  (38,  39).  The  evolutionary
14distances  among  S. pombe,  S. cerevisiae  and  multicellular  organisms  also  make  it useful
to  identify  potent  functional  motifs  by  comparing  structures  among  their  homologues.
We  now  report  the  primary  structure  of  a  novel  gene,  Spfkp39+  which  was
isolated  as  a  FKBP-type  PPIase  in  S. pombe.  Comparative  studies  using  primary
structures  of  FKBPs  indicate  that  FKBPs  can  be  classified  into  four  groups  on  the  basis
of  differences  in  primary  structures  of  catalytic  domains.  This  may  allow  one  to  predict
subcellular  localization  of  FKBPs  from  primary  structures,  not  of  localization  signals,
but  of  catalytic  domains.  We  also  determined  several  biochemical  characteristics  of
SpFkbp39p  by  showing  nuclear  localization  as  well  as  identifying  several  novel
structural  motifs,  which  are  specific  for  the  nuclear-type  FKBP  group.
151.2  Experimental  procedures
1.2.1  Isolation  of  a  S. pombe  DNA  fragment  containing  fkp39+  by  PCR  using
degenerate  oligonucleotide  primers
General  methods  for  DNA  manipulation  were  as  described  (40).  Two  degenerate
oligonucleotide  PCR primers  (5'-SAR  GTI ATH MRI  GSI TGG-3'  and  5'-ARY TCI ACI
TCR AAI RYI ARI  GT-3'.  I, inosine;  S, cytosine  or guanine;  R, adenine  or guanine;  H,
adenine,  thymine  or  cytosine;  M,  adenine  or  cytosine;  W,  adenine  or  thymine;  Y,
cytosine  or thymine)  designed  from  the  sequences,  E/Q-V-I-K/R-A/G-W  and  T-L-V/T-
F-E/D-V-E-L,  of the catalytic  domains  conserved  among  FKBPs,  were  used to  amplify
DNA  fragments  from  S.pombe  genomic  DNA  by  Polymerase  Chain  Reaction  (PCR).
PCR  amplification  was performed  using  Taq DNA polymerase  (Boehringer  Mannheim),
manufacturer's  buffers  and  GeneAmp  PCR  System  9600  (Perkin  Elmer).  The  PCR
protocol  cycles  was  for  30  sec  at  95,  2min  at  40  and  1min  at  72.  The
resulting  PCR products  were  subcloned  into pBluescriptIISK  (-)(Stratagene)  at the  SmaI
site  and  the  nucleotide  sequences  were  determined  using  Dye  Terminator  Cycle
Sequencing  Ready Reaction  DNA  sequencing  kits  (Perkin  Elmer)  and a DNA sequencer
ABI377  (Perkin  Elmer),  according  to the manufacturers'  instructions.
1.2.2  Isolation  of  S.pombe  genomic  DNA  fragments  containing  full-length  fkp39+
16To isolate  the full-length  open reading  frame,  PCR-amplified  DNA fragments  were used
to  screen  the  S.  pombe  genomic  library  (provided  by  Dr.  A.  Ishihama)  by  plaque
hybridization,  using  the  Gene  Images  random  prime  labeling  and  detection  system
(Amersham),  according  to  the  manufactures'  instructions.  The  three  independent
positive  clones  isolated  were  digested  with  ApaI  and  XhoI  and  subcloned  into
pBluescriptIISK  (-)(Stratagene)  all  at  the  same  sites.  This  plasmid  was  named  pBS-
Spfkp39+.  Nucleotide  sequences  of these  clones  were  determined  on  both  strands,  as
described  above.  This  nucleotide  sequence  has  been  submitted  to  the 䝥湂慮欠 荇 睩瑨
accession  number  AF017990.
1.2.3  Construction  of  plasmids  which  express  Fkbp39p  protein
BamHI  and NdeI  sites were  engineered  at the  translation  initiation  site and  BamHI  site
at the translation  stop codon  of SpFkbp39p  by  PCR.  Two primers  5'-GCG  GAT CCA
TAT GTC  TCT  TCC  AAT TGC  TG-3',  which  has  BamHI  and  NdeI  sites,  and  5'-CCG
GAT CCT TAG TGA ACG  CGA ACA AGC  TTG ACT  TC-3',  which  has a BamHI  site,
were  used  to  amplify  the  fragment  from  pBS-Spfkp39+  plasmid.  This  fragment  was
subcloned  into  pBluescriptIISK  (-)(Stratagene)  at  BamHI  sites,  as  described  above.
This  vector  was  named  pBS-Fkbp39p.  pBS-Fkbp39p  was  digested  at  NdeI  and
BamHI  sites  and  was  subcloned  into  6His-pET 11  d  (41)  and  pREP 1  HA2  (T. Kuzuhara
17and  M.  Horikoshi,  unpublished  results),  a  pREP1  (42)-based  S.pombe  vector  which
expresses  proteins  with two  copies  of the  influenza  virus  hemagglutinin  (HA)  sequence
(YPYDVPDYA)  appended  to  its  NH2-termini.  The  resultant  plasmids  were  named
pET11d-6His-Fkbp39p  and pREP1-HA-Fkbp39p,  respectively.
1.2.4  [3H] dihydro-FK506  binding  assay
Binding  of [3H] dihydro-FK506  (NEN)  was determined  using  the LH-20 assay  (25) with
ㄲ湍嬳䡝摩桹摲漭䙋㔰㘠 慮搠 〮ㄠ 草 䴠 印䙋䉐㌹瀠 楮 ㈰浍 呲楳Ⱐ 灈㜮㔬 ㈰ね
NaCl.  Bound  [3H] dihydro-FK506  was  separated  from  free  [3H] dihydro-FK506  by
chromatography  on  individual  Sephadex  LH-20  columns  (Pharmacia).  Samples  were
fractionated  and counted  in an LS-6000LL  scintillation  counter  (Beckman  instruments).
1.2.5  Determination  of  subcellular  localization  of  SpFkbp39p
The  plasmid  pREP1-HA-Fkbp39p,  pREP1-HA-TBP  (T. Yamamoto  and  M.  Horikoshi,
unpublished  results)  and  mock  plasmid  pREP1  were  transformed  into  S.  pombe  strain
JY741  (h-ade6-M216  leul  ura4-D18),  using  general  methods.  Staining  of these  yeast
cells  by  indirect  immunofluorescence  was  done  essentially  as described  (44)  but with
the  following  modification.  Cells  were  cultured  in  the  4ml  of  adenine  and  uracil
18complemented  MM  medium  (MMAU)  to  106cells/ml.  Cell  walls  were  removed  by
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1.2.6  Peptidyl-prolyl  cis/trans-isomerization  activity  of  recombinant  FKBPs
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succinyl-Ala-Leu-Pro-Phe-p-nitroanilide  (Bachem).  The  release  of  p-nitroanilide  is
quantitated  spectrophotometrically  at  390  nm.  Reactions  (1ml)  were  at  0  and
contained  0.17mM  substrate,  50  mM  Hepes-Na  (pH  8.0),  100mM  NaCl,  FKBPs  and
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1mg/ml)  was added.  After  mixing,  the increase  in absorbance  at 390nm was measured
in a Beckman  DU680  spectrophotometer  at  1s  intervals  (Fig.  3).  The first  order  rate
constant,  k (s-1),  was calculated  from the slope of the resulting  line (Table  1).
191.2.7  Method  of  computer  analysis
CLUSTAL  W (46) was  used  for the  alignments  of amino  acid  sequences  and  NJPLOT
for  the  determination  of  the  phylogenetic  tree.  The  three-dimensional  structure  of
HsFKBP12  was  drawn  and  analyzed  with  RasMac  (ver.  2.5).  Other  analyses  were
performed  by GENETYX-MAC  (ver. 9.0) (SOFTWARE  DEVELOPMENT  CO., LTD.).
201.3  Results
1.3.1  Isolation  of  fpk39+  gene
To  isolate  novel  S.  pombe  nuclear-type  PPIase  genes,  PCR  was  carried  out  using
degenerate  oligonucleotide  primers  based  on the conserved  catalytic  domains  of FKBPs.
The  amplified  S.  pombe  genomic  DNA  fragments  were  isolated  and  nucleotide
sequences  determined.  The deduced  amino  acid  sequence  encoded  a fragment  (arrow
under  the  nucleotide  sequence  (1525-1665)  in  Fig.  1) showing  high  similarity  (over
40% identity)  to the catalytic  domains  of other FKBPs.  To obtain the full-length  clone,
we  screened  a  S.  pombe  genomic  library,  using  this  PCR  fragment  as a probe.  Three
independent  positive  clones  were isolated  and  nucleotide  sequences  were  determined.
An open  reading  frame  (ORF)  is located  from 601  (start  codon:  601-603)  to
1685  (stop  codon:  1686-1688)  (Fig.  1).  An  in-frame  stop  codon  locates  six  bases
upstream  (position  595-597,  underlined  in Fig.  1) of the putative  translation  initiation
site.  There  are no  consensus  sequences  for donor,  acceptor  or branch  sites for splicing
in this  region  (46).  The deduced  amino  acid sequence  of this  ORF is most  like that of
S.cerevisiae  FKBP-type  PPIase,  Fpr3  (45%  identity)  (27, 28),  consisting  of 361  amino
acids  (39, 301  daltons)  with  the FKBP  catalytic  domain  located  at the  C terminal  region
(267-361,  double  underlined  in  Fig.  1).  Two  putative  nuclear  targeting  sequences
which  consist  of bipartite  short  stretches  of basic  amino  acids with non-conserved  linker
regions  (47)  located  in  positions  184-209  and  215-239  (boxed  (basic  stretch)  and
21dotted-lined  (linker)  in  Fig.  1), suggesting  nuclear  localization.  Taken  together  with
the results  shown  above,  we conclude  that this  isolated  gene  encodes  a putative  nuclear-
type  FKBP, named  SpFkbp39p,  most  likely  to be the  S.  pombe  homolog  of S. cerevisiae
Fpr 3.
1.3.2  SpFkbp39p  binds  to  FK506  and  has  PPIase  catalytic  activity
The  primary  structure  of the  COOH-terminal  region  of SpFkbp39p  is  similar  to those
found  in  catalytic  domains  of  FKBPs.  FKBP-type  PPIases  interact  with  FK506  and
their  PPIase  enzymatic  activities  are  inhibited  by  these  interactions.  To determine  if
SpFkbp39p  has  biochemical  characteristics  of  FKBP-type  PPIases,  we  prepared
bacterial-expressed  SpFkbp39p  protein.  The  plasmid  pETlld-6His-Fkbp39p,  which
expresses  His-tagged  SpFkbp39p  in Escherichia  coli,  was constructed  and  recombinant
His-tagged  SpFkbp39p  (His-SpFkbp39p)  was  purified  by  Ni-agarose  chromatography
as  described  in  Experimental  Procedures.
We first  observed  the  interaction  between  SpFkbp39p  and  FK506.  Purified
recombinant  His-SpFkbp39p  bound  [3H]dihydro-FK506,  which  was  detected  by  the
LH-20  assay  (25)(Fig.  2B).  Next,  we  measured  PPIase  catalytic  activity  of
SpFkbp39p  by  enhancement  of the  rate  of  chymotrypsin  cleavage  of a  synthetic  Pro-
containing  peptide  substrate  in a coupled  spectrophotometric  assay  (1, 43).  This assay
demonstrated  that  His-SpFkbp39p  protein  has PPIase  activity  comparable  to HsFKBP 12
22(control),  and  that  this  enzymatic  activity  is  also  almost  perfectly  inhibited  by  the
FK506  (Fig.  3).  The  specific  activities  (kc/Km)  of  these  molecules  in  reactions  are
summarized  in Table  1, which  shows  that  the kc/Km  of control  enzyme,  HsFKBP12  is
similar  to that of previous  data  (1, 43), and  that the  kc/Km  of SpFkbp39p  is almost  half
that of HsFKBP12.  Taken together,  the results  obtained  from these  biochemical  assays
indicate  that  SpFkbp39p  has FKBP-type  PPIase  activity  in vitro.
1.3.3  Classification  of  FKBPs  by  primary  structure  of  catalytic  domains
Distinct  FKBPs  are  localized  to different  cellular  compartments  (21).  It is speculated
that  differences  in  the  primary  structures  of  catalytic  domains  reflect  differences  in
subcellular  localization  of FKBPs  because  the  substrates  and/or  interactors  of FKBPs
might  differ  in  each  cellular  compartment.  Therefore,  we  compared  the  primary
structure  of  SpFkbp39p  with  eukaryotic  FKBPs  in  order  to  elucidate  the  relationship
between  the primary  structure  and  subcellular  localization  of FKBPs.
Phylogenetic  tree  analysis  based  on  the  primary  structures  of  catalytic
domains  of known  FKBPs  (Fig.  4)  indicated  that  40  FKBPs  can  be  classified  mainly
into  four  groups  (group  A  to  D),  excluding  only  four  FKBPs.  Surprisingly,  this
classification  corresponds  to  categorization  by  subcellular  localization  of each  group;
localized  in nucleus  (group A),  cytoplasm  (group  B), nucleus  or nucleus  and  cytoplasm
(group  C)  and  ER (group  D).  This  observation  may  make  feasible  prediction  of the
23subcellular  localization  of  FKBPs  from  primary  sequences  of  catalytic  domains.
1.3.4  Detailed  analysis  of  amino  acid  residues  of  catalytic  domains
FKBPs  are  classified  into  four  groups  by  primary  structure,  as  shown  in  Fig.  4.  To
examine  whether  this  classification  of FKBPs  reflects  differences  in amino acid residues
among  each group  protein,  we mapped  the  "conserved"  and  "group-specific"  residues  to
alignment  of the  primary  structures  of FKBPs  (Fig.  5A).  We defined  the  amino  acid
residues  with  over  90%  identity  and  100%  similarity  in  all  groups  as  "conserved"
residues  (blue-and  red-,  and  cyan  shadowed,  respectively,  in Fig.  5A),  and  the  amino
acid  residues  which  are  completely  identical  and  similar  within  one,  two  or  three
group(s)  except  "conserved"  residues  as  "group-specific"  residues  (green-shadowed  in
Fig.  5B).  The  alignment  shows  that  both  "conserved"  and  "group-specific"  residues
are  not  closely  located  to  a  part  but  rather  located  to  catalytic  domains  in  a  non-
consecutive  manner.  However,  it is possible  that these  residues  might  form  functional
regions  and thus be located  together,  at the three-dimensional  level.
To define  the presence  of the putative  functional  domains  discussed  above,  we
mapped  these  conserved  and group-specific  residues  to these  corresponding  positions  in
the three-dimensional  structure  of human  FKBP12  (HsFKBP12)  the tertiary  structure  of
which  has been  determined  (48,  49)  (Fig.  5B and  Fig.  5C).  The  similarity  of primary
structures  and  tertiary  structures  (FKBP12  (group  B)  (48, 49),  FKBP52  (group  C2) (50)
24and  FKBP25  (group  C1)(J.  Liang,  D.  T.  Hung,  S.  L.  Schreiber  and  J.  Clardy,
unpublished  results  shown  in PDB  database))  of catalytic  domains  of FKBPs  suggests
that the backbone  structure  of the catalytic  domains  of most FKBPs  should  be similar  as
well.  As a result,  the  "conserved"  residues  (blue,  red  or cyan  in Fig.  5) are located  in
proximity  (Fig.  5B) and some  form  a hydrophobic  pocket  (48, 49) which  is required  for
FKBP-immunoretardant  interactions  and  basal  PPIase  activity.  Interestingly,"group-
specific"  residues  (green  in Fig.  5) are also  located  together  in several  regions  and  sites
which  have  not been  described  (circled  in Fig.  5B  and  5C)  although  these  residues  are
located  in a  non-consecutive  manner  in primary  structure.  Because  these  regions  and
sites  consist  of  group-specific  residues  which  exist  in  FKBPs  in  a  group-specific
manner,  they  might  be  involved  in  "group-specific"  functions  and  for  which  our
classification  of  FKBPs  by  phylogenetic  tree  based  on  primary  structure  of  catalytic
domains  can be appropriate.
Several  FKBPs  interact  with  specific  molecules  (9-11,  13,  14).  It would  be of interest
to  investigate  whether  "group-specific"  regions,  as  shown  above,  are  required  for
interactions  between  FKBPs  and known  interactors.  If so, this  will lead to elucidation
of the  "group-specific"  function  of FKBPs.
1.3.5  Nuclear  localization  of  SpFkbp39p
We  proposed  the  presence  of  four  FKBP  groups  and  group-specific  regions.  From  this
25proposal,  SpFkbp39p  is  predicted  to  localize  to  the  nucleus.  This  provides
experimental  support  of our  hypothesis  on  the  relationships  between  primary  structure
of  catalytic  domains  of. FKBPs  and  their  subcellular  localization.  We analyzed  the
subcellular  localization  of  SpFkbp39p,  using  the  fluorescence  antibody  technique  to
elucidate  localization  in  the  cell.  We  expressed  HA-tagged  SpFkbp39p  and  TBP
(TATA box-binding  protein)  in  S.  pombe  cells  and  an  anti-HA  antibody  was  used  for
detection.
This  analysis  revealed  that  the  nucleus  (stained  with  Hoechst  33342)  of the  resultant
cells  carrying  pREP1-HA-SpFkbp39p  was  stained  with  FITC,  similar  to  the  control
cells carrying  pREP1-HA-TBP  (Fig. 6),  which  indicates  that  SpFkbp39p  is localized  to
the  nucleus.  This  observation  supports  the  validity  of our  prediction  on  subcellular
localization  of the FKBP  family.  Further  investigations  are expected  to define rules  on
subcellular  localization  of FKBPs.
261.4  Discussion
1.4.1  Characteristics  of  group  A  FKBPs
The newly  isolated SpFkbp39p is classified into nuclear-type group A with five other
known  FKBPs,  and  SpFkbp39p  is  localized  to  the  nucleus  (Fig.  6).  To  identify
conserved  structural  motifs  other  than  the  catalytic  domain  which  might  act  as  a
functional domain, we compared the full-length primary structures of group A FKBP
with members of other group FKBPs.  Interestingly, group A proteins have long NH2-
terminal regions adjacent to the catalytic domains (Fig. 7B).  Alignment among group
A proteins in these regions demonstrates that they have two novel conserved domain
structures specific for group A FKBPs which were named conserved domains I (15%-
41% identity and 41%-70%  similarity) and II (30%-55%  identity and 50%-70%
similarity),  as shown  by the colored-box  in Fig. 7A.  They also contain  acidic (in
SpFkbp39p, underlined in Fig. 1, and red-lined above in Fig. 7A) and basic (bold in Fig.
1, and blue-lined above in Fig. 7A) regions (26, 27, 51, 52) which are also rich in both
Ser and Thr residues (Fig. 7A).  Their orders of each domain and region are the same
(Fig.  7B),  suggesting that not  only the primary  structure but  also positions of  each
domain and region might be  significant for the functional roles of group A proteins.
This  domain structure is not present  in other groups (ScFprl  (group B), HsFKBP52
(group  C1), HsFKBP25  (group  C2) and  ScFpr2 (group D)) (Fig. 7B), and  strongly
suggests that group A FKBPs form a functional subfamily.  The primary structures of
27yeast  and  insect  group  A  FKBPs  differ  in the  NH2-terminal  regions.  Therefore,  we
designated  this  a "species-specific"  region  (Fig.  7B),  suggesting  that there  is functional
diversity  among  group A.
1.4.2  Conclusion  and  perspective
In  conclusion,  we  isolated  a  novel  S.pombe  gene  product,  SpFkbp39p,  which  forms  a
nuclear-type  subfamily  with  several  FKBPs.  This  subfamily  is  classified  according  to
differences  in  the  primary  structures  of  FKBP  catalytic  domains.  SpFkbp39p  has
biochemical  properties  similar  to  those  of  other  FKBPs.  Moreover,  we  identified
novel  domain  structures  conserved  in the  N-terminal  regions  found  only  among  nuclear
type  FKBPs.  These  structural  motifs  include  both  negatively-and  positively-charged
regions  which  might  interact  with  positively-charged  proteins  in  the  nucleus,  such  as
histones,  and  acidic  molecules,  such  as  DNA,  respectively.
28Chapter  Two
A  nuclear  FK506-binding  protein  (FKBP)  has  a  histone
chaperone  activity  and  regulates  rDNA silencing
2.1  Introduction
Alterations  in chromatin  structure  are important  in regulating  the access  to  DNA
of the complex  machinery  that  controls  nuclear  phenomena  such as gene expression  (1).
Changes  in  chromatin  structure  are  effected  by  both  enzymatic  and  non-enzymatic
activities  (2);  examples  of  the  latter  include  the  actions  of  histone  chaperones  (3-5).
These  proteins  mediate  nucleosome  assembly  and  disassembly,  and  these  dynamic
alterations  in  nucleosome  structure  in  turn  influence  nuclear  events  (3-5).  Histone
chaperones  function  in concert  with  enzymes  such as chromatin-remodeling  factor  and
chromatin-modifying  enzyme  to stimulate  or inhibit  processes  such as DNA  replication
and transcription  (4, 5).
Peptidyl  prolyl  cis/trans  isomerase  (PPIase)  enzymes  alter  the  orientation  of
peptide  chains  at  proline  residues,  thereby  aiding  proper  protein  folding  (6).  PPlases
have  been  classified  into three  subfamilies  (FKBP,  Cyp and Pinl)  and  are reported  to be
localized  in  the  nucleus  and/or  cytosol  (7).  Nuclear  FKBP  proteins  possess  other
29elements  in addition  to the  PPIase  domain  (8).  In  addition  to the  diversity  of PPIases
with  respect  to their  structure  and  localization,  recent  data indicate  that PPIases  function
by  associating  with  other  proteins,  thereby  modulating  their  activities  (6, 7).  For
example,  in the  nucleus,  the  DNA-binding  activity  of the  c-Myb  transcription  factor  is
negatively  regulated  by  its  stable  interaction  with  Cyp40  (9).  In  addition,  FKBP52
inhibits  the DNA-binding  and  transactivation  properties  of the transcription  factor  IRF-
4 (10).  Moreover,  the multi-domain  PPIases  FKBP51  and/or  Cyp associate  with steroid
receptors  in  heterocomplexes  to modulate  receptor  activity  (11-13)  via  their  additional
domains  in vitro.  Furthermore,  the  intranuclear  prolactin/cyclophilin  B complex  acts as
a  transcriptional  inducer  (14),  and  another  nuclear  PPIase,  Pinl , regulates  a  subset  of
mitotic  phosphoproteins  and  restores  the  function  of  the  Alzheimer-associated
phosphorylated  tau  protein  (15).  Pinl  also  interacts  with  the  Cdk9-phosphorylated
hSpt5  subunit  of  the  transcription  elongation  factor  DSIF  (16),  and  generates
conformational  changes  in  p53  that  enhance  its  transactivation  activity  (17-19).
Collectively,  these  results  suggest  that  PPIases  regulate  protein  activity  by  controlling
the assembly  and/or  disassembly  of multiple  protein  complexes  (7).
We  speculated  that  nuclear  PPIases  may  contribute  to  the  dynamics  of
chromatin  complex  assembly  and/or  disassembly  because  they  have  been  reported  to
interact  with basic  chromatin  components.  For example,  the S. cerevisiae  nuclear  PPIase
Fpr3  binds  to  a  histone  H2B  nuclear  localization  signal  (20).  Moreover,  Essl,  a  yeast
homologue  of  Pinl,  was  shown  to  be  genetically  linked  to  histone  deacetylase  Rpd3
(21, 22).  In  addition,  FKBP25  has  been  reported  to  associate  with  histone  deacetylase
30(23).  However,  it has  not  been  tested  whether  PPIases  themselves  can  alter  chromatin
structure.
We  previously  isolated  a  nuclear  FKBP  from  S.  pombe,  termed  SpFkbp39p,
which  has  a  charge-rich  domain  and  two  conserved  domains  in  its  N-terminus,  in
addition  to a C-terminal  PPIase  domain  (8). We predicted  that SpFkbp39p  could  interact
with histones  and DNA (8). In this  study, we show that nuclear  FKBP has dual functions,
namely,  histone  chaperone  activity  and  PPIase  activity,  and  that  it  is  required  for
silencing  at  the  rDNA  locus.  Furthermore,  we  show that  the  PPIase  pocket/domain  of
nuclear  FKBP  regulates  silencing  at  the  rDNA  locus  and  that  nuclear  FKBP  associates
chromatin  in  vivo.  This  is  the  first  report  showing  that  a  nuclear  PPIase  influences
chromatin  organization  both in vitro  and in vivo.
312.2  Experimental  procedure
2.2.1  Plasmid  construction  and  purification
Plasmids  were  constructed  as  described8.  Briefly,  the  coding  regions  of  SpFkbp39p
and  its mutant  derivatives  were  subcloned  into  6His-pET11d  at  the  NdeI  and  BamHI
sites51,  and  the  coding  regions  of Fpr4  and  mutants  derivatives  were  subcloned  into
pET-28a (+)  at  the  BamHI  and  XhoI  sites  (Novagen).  Point  mutations  were  introduced
into Fpr4  plasmids  by using  a PCR  method.  Recombinant  SpFkbp39p  and  Fpr4 proteins
were  expressed  in E.  coli  with  an amino-terminal  histidine-tag  to  facilitate  purification
by  Ni2+  affinity  chromatography51.  pET-6His-SpFkbp39p,  pET-28a (+)-Fpr4  and
constructs  encoding  truncated  derivatives  were  transformed  into  E.  coli  BL21(DE3).
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thiogalactopyranoside,  harvested  and  disrupted  by  sonication  (Branson)  in  buffer
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mercaptoethanol.  The  cleared  lysate  was  applied  onto  ProBond  resin  (Invitrogen)  and
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SpFkbp39p  proteins  were  further  purified  by  POROS  20S  ion-exchange
chromatography  using  the  BIO-CAD  system  (PerSeptive),  POROS  20HS
chromatography  and  dye-column  chromatography,  respectively.  Fpr4  WT  and  point-
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POROS  PI  chromatography,  respectively.  The  purity  of  the  SpFkbp39p  and  Fpr4  WT
32and  truncated  and  point-mutated  proteins  was  over  90  %,  as  estimated  by  SDS
polyacrylamide  gel  electrophoresis  and  Coomassie  staining  (Figs.  lb,  3e, 4b  and  7c).
Recombinant  FKBP12  protein  was  purchased  from  Sigma  Co.,  Ltd.  Protein
concentrations  were  determined  using  the  Bradford  assay  (Bio-Rad)  using  BSA  as the
standard.
2.2.2  Histone  chaperone  assay
Closed  circular  plasmid  DNA  (pBluescript)  was  relaxed  using  wheat  germ
topoisomerase  I (Promega).  The relaxed  circular  DNA  (0.1 pmol;  treated  with  5 units of
topoisomerase  I) was  combined  with  purified  SpFkbp39p  protein  or other  proteins  (7
pmol)  and  HeLa  core  histones  (52)  (4 pmol)  in assembly  buffer  (10 mM TrisCl pH  7.5,
150 mM NaC1, 2 mM  MgC12, 0.5 mM DTT  and  0.1 mg/ml  BSA;  50 ml  final volume).
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the reaction  after  adding  an equal  volume  of stop A buffer  (20 mM EDTA pH  8.0,  1 %
(w/v)  SDS  and  200  mg/ml  proteinase  K).  Plasmid  DNA  was  extracted  using  phenol-
chloroform,  and  precipitated  with  ethanol.  The  purified  plasmid  was then  subjected  to
1%  agarose  gel  electrophoresis.
2.2.3  Nucleosome  arrays  analysis
33Relaxed  circular  DNA  (0.3  pmol;  relaxed  with  15  units  of  topoisomerase  I)  was
combined  with  purified  recombinant  SpFkbp39p  (16  pmol)  or  other  factors  and  HeLa
core  histones  (20  pmol)  in  the  assembly  buffer  (50  ml)  described  above,  and  then
楮捵扡瑥搠 慴 ㈷膎 景爠ㅨ爮 呯 瑨楳 睡猠 慤摥搠 ㄰ね䴠 䍡䍬㈠ 慮搠 䵎慳攠 ⠱⸳Ⱐ ㈮㔠潲
唩 景汬潷敤 批 楮捵扡瑩潮 慴 ㌷膎 景爠ㅭ楮⸠ 周攠 牥慣瑩潮 睡猠 獴潰灥搠 批 慤摩湧 慮
equal  volume  of stop B buffer  (20 mM EDTA pH 8.0 and  1%  SDS).  Digested  DNA was
purified,  subjected  to  1.5%  (w/v)  agarose  gel  electrophoresis  and  visualized  by
ethidium bromide staining.
2.2.4  Yeast  strain  and  fpr4  null  mutant
The  genetic  backgrounds  of the  yeast  strains  used  are  summarized  in  Supplementary
Table  1 online.  The  FPR4  gene  was replaced  with  the Candida  glabrata  LEU2  gene  in
haploid  yeast  (JS237)  by  a  PCR-based  procedure  (53).  The  sequences  of  oligo  DNA
used  for  disruption  are  described  in  Supplementary  Table  2.  The  fpr4:: LEU2
replacement  was confirmed  by PCR  (see Supplementary  Table  2) and restriction  (NdeI)
analysis.
2.2.5  Immuno-fluorescence  analysis  to  determine  cellular  localization
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et al.  55. Briefly,  fixed  yeast  cells  were  washed  with  PBS  containing  0.1%  Triton  X-100
and  0.1%  NP-40  before  antibody  treatment.  A  1:200  diluted  anti-HA  mouse
monoclonal  antibody  (12CA5)  and  a 1:1000 diluted  anti-Sir2p  goat polyclonal  antibody
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through  the  FPR4  promoter  on  the  single  copy  plasmid  (pRS316  derivatives).
Thereafter,  1:200  diluted  anti-mouse  TRITC-conjugated and  1:200 diluted  anti-goat
FITC-conjugated  antibodies  were  used  as  the  second  antibodies.  A  Laser  Scanning
Microscope  (LSM  5  PASCAL  and  LSM  510,  Carl  Zeiss)  was  used  to  observe  the
immuno-stained  yeast  cells  (57).  DNA  was  stained  with  Hoechst  33342  and  was
visualized  by a blue  diode laser  (Carl Zeiss).
2.2.6  Chromatin  immunoprecipitation  (ChIP)
The procedure  for  the ChIP  assay  has been  described  before  (37). For the IP, Fpr4p  was
tagged  with the  Flag-epitope  at its C-terminus  in the native  chromosome  and  10 micro  L
of anti-Flag  antibody  agarose  (Sigma)  was  used  to precipitate  the  Flag-tagged  protein
from 200  mL of whole-cell  extracts.  Quantitative  PCR  was performed  by using  the ABI
PRISM  7000  Sequence  Detection  System  (Applied  Biosystems).  SYBR  Green  I  dye
was  used  as a  DNA  binding  dye  for real-time  detection  during  PCR.  We used  12/1000
35of  the  immunoprecipitates  as  templates  in  a  30  mL  PCR  reaction  containing  50  nM  of  a
specific  primer  set.  To  quantify  the  input  DNA  of  each  sample,  the  DNA  from  0.24  ml
of  the  whole  cell  extract  was  used.  The  input  DNA  corresponding  to  0.9,  0.23,  and
0.056  ml  of  whole-cell  extracts  from  wild-type  cells  was  used  to  construct  a  standard
curve  that  would  allow  us  to  estimate  the  initial  amount  of  DNA  in  each  sample.  Primer
Express  software  (Applied  Biosystems)  was  used  to  design  primers  that  would  allow
various  chromosomal  regions  to  be  detected.  Preparation  of  the  reaction  mixtures  and
the  PCR  amplification  procedure  were  performed  according  to  the  manufacturer's
instructions.
2.2.7  Indirect  end-labeling  assay  of  chromatin  at  the  rDNA  locus
Indirect  end-labeling  analysis  at  the  rDNA  locus  was  performed  as  described38.  The  null
mutant  of  the  nuclear  FKBP  gene  constructed  in  this  study  was  used  for  the  analysis.
Yeast  nuclei  were  prepared  from  1  liter  of  SC  cultures  using  the  percoll  gradient  method
and suspended  in SPC buffer  (20 mM Pipes  pH 6.5, 0.1 mM CaCl2,  1 M sorbitol,  1 mM
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10  min.  The  DNA  was  then  extracted  with  proteinase  K  and  phenol/chloroform,
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then  transferred  to  charged  nylon  membrane O/N  (Gene  Screen+;  NEN)  using  the
36aspiration  blot  method  and  cross-linked  to  the  membrane  by  UV  light.  Southern  blot
hybridization  using  the phosphatase-labeled  (Amersham)  DNA probes  P2 and P6 of the
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(Amersham  hybridization  buffer).  Nonspecific  binding  of  probes  was  eliminated  by
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manufacturer's  protocol.  Autoradiography  was  performed  for  three  minutes  using  a
Gene  Image  CDP-Star  detection  system  (Amersham).  Hybridization  specificity  was
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2.2.8  rDNA  silencing  assay
Silencing  at the rDNA  locus was assayed  in wild type  cells (JS237)  or in the fpr4::LEU2
disruptant  expressing  full  length,  truncated  or  point-mutated  versions  of  Fpr4p.  Fpr4p
expression  plasmids  were  constructed  by  amplifying  the  FPR4  gene  and  500  by  each  of
the  promoter  and  terminator  regions  from  S.  cerevisiae  genomic  DNA  and  subcloning
these  into  the  single  copy  plasmid  pRS316.  Deletions  and  point  mutations  were
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cells.  Overnight  cultures  of  yeast  strains  at  30  1 were  harvested  and  RNA  was  extracted
with  the  glass  beads/phenol-chloroform  method.  RNA  transcribed  from  MET  15
integrated  at  the  rDNA  locus  and  from  the  control  ADH1  gene  was  analyzed  by  RT-
PCR.
372.2.9  Real  time  quantitative  RT-PCR  analysis
Quantitative  one-step  RT-PCR  was  performed  using  the  ABI  PRISM  7000  Sequence
Detection  System  (Applied  Biosystems)  and  SYBR  Green  RT-PCR  reagents  (Applied
Biosystems).  We used  0.5 mg of the total RNA as the template  in a 50 mL PCR  reaction
containing  50  nM  of  a  specific  primer  set  designed  for  quantitative  PCR.  In  addition,
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construct  a  standard  curve  to  estimate  the  initial  amount  of  RNA  in  each  sample.  The
target  mRNA  level were  calculated  as (reverse  transcriptase  (+)-  reverse  transcriptase
(-)).  The  preparation  of  the  reaction  mixtures  and  the  PCR  amplification  procedure
followed  the  manufacturer's  instructions.  Primer  Express  software  (Applied
Biosystems)  was used to design  primers  for detecting  the genes.
382.3  Results
2.3.1  Nuclear  FKBP  is  a  histone  chaperone
To  determine  whether  nuclear  FKBP  directly  alters  chromatin  structure,  we  examined
the  histone  chaperone  activity  of  SpFkbp39p8  using  DNA  supercoiling  (24, 25)  and
micrococcal  nuclease  (MNase)  digestion  assays  (24, 25)  as  shown  in  Figure  8.  In
comparison  to  buffer  alone,  which  had  no  effect,  SpFkbp39p  induced  the  supercoiling
of  plasmid  DNA  in  a  histone-dependent  manner  as  efficiently  as  the  known  histone
chaperone  NAP-I  (Fig.  8a-c),  which  indicates  that  SpFkbp39p  promotes  nucleosome
assembly.  A  mixture  of  SpFkbp39p  and  core  histones  in  a  1:2  ratio  was  sufficient  for
nucleosome  assembly  (Fig.  8d,  lane  5)  and  the  reaction  reached  saturation  when  the
molar  ratio of SpFkbp39p  to core  histones  was approximately  2:1 (Fig. 8d, lane 7). This
molar  ratio  can  be explained  by  the  fact that  core  histones  consist  of two  (H3/H4  and
H2A/H2B)  dimers.  Therefore,  SpFkbp39p  reacts  with  core  histones  in  a
stoichiometrically  relevant  manner  in  the  histone  chaperone  assay,  which  is  consistent
with the known  properties  of other  histone  chaperones  (3).
We  also  examined  the  distribution  of  the  nucleosomal  arrays  assembled  by
SpFkbp39p  by  using  the  MNase  digestion  assay.  After  partial  MNase  digestion,  the
DNA  was  extracted  and  analyzed  by  agarose  gel  electrophoresis.  We  detected  mono-
and  di-nucleosomes  (approximately  140  and  280  bp  DNA  fragments)  in  reactions
containing  SnFkbn39n  (Fig.  8e):  mononucleosomes  have  previously  been  shown  to
39contain  approximately  146 by of DNA  (24, 25). These  findings  suggest  that  SpFkbp39p
assembles  nucleosomes.  Thus,  the  results  of  the  supercoiling  and  MNase  digestion
assays  demonstrate  that  SpFkbp39p  has histone  chaperone  activity  in vitro.
2.3.2  Novel  feature  as  histone  chaperone
During  the  purification  of  SpFkbp39p,  we  observed  that  it binds  to  anionic  resins,  which
indicates  that  at  least  part  of  the  surface  of  the  protein  is  basic.  This  is  in  contrast  to
classical  histone  chaperones  like  NAP-I,  which  are  acidic  and  thereby  interact  with
histones.  We  therefore  investigated  whether  SpFkbp39p  and  acidic  histone  chaperones
differ  functionally  with  respect  to  the  nucleosome  assembly  reaction.  Incubation  of
acidic  histone  chaperones  with  histones  prior  to  nucleosome  assembly  is  known  to
increase  their activities  (24, 25). Thus,  we determined  whether  this pre-incubation  affects
the  nucleosome  assembly  activity  of  SpFkbp39p  (Fig.  9a).  NAP-I  required  pre-
incubation  with  histones  for  stronger  histone  chaperone  activity  (Fig.  9b,  lanes  3, 6, 9
and  12).  Unexpectedly,  however,  SpFkbp39p  did  not  show  better  histone  chaperone
activity  upon  pre-incubation.  Indeed,  it  exhibited  decreased  activity  after  pre-incubation
(Fig.  9b,  lanes  2,  5,  8  and  11). This  observation  suggests  that  SpFkbp39p  mediates
nucleosome  assembly  by  a  mechanism  that  is  different  from  that  used  by  previously
characterized  histone  chaperones.
402.3.3  Histone  chaperone  and  PPIase  domains
We  next  performed  two  experiments  to  determine  whether  the  PPIase  activity  of
SpFkbp39p  contributes  to  its  novel  histone  chaperone  activity.  First,  we  determined
whether  cytosolic  FKBP12,  which  does  not possess  any  other  domains  apart  from  the
PPIase  domain,  exhibits  histone  chaperone  activity.  Second,  we  tested  whether  the
PPIase  inhibitor  FK506  (26, 27)  also  inhibits  nucleosome  assembly.  We observed  that
FKBP12  did not possess  histone  chaperone  activity  (Fig.  10a,  b) and  that FK506  did not
inhibit  histone  chaperone  activity  (Fig.  10c) at  a concentration  that inhibited  the PPIase
activity  of SpFkbp39p8.  Therefore,  we  conclude  that  the  PPIase  activity  of SpFkbp39p
is not essential  for its histone  chaperone  activity.
To determine  whether  the N-terminal  domain  (1-256  residues)  of  SpFkbp39p  is
sufficient  for  the  histone  chaperone  activity  of the  protein,  we  performed  assays  with
truncated  variants  of  SpFkbp39p  (Fig.  10d, e). Both  the  wild  type  (WT)  protein  and  an
N-terminal  derivative  of  SpFkbp39p  lacking  the  PPIase  domain ⢁ꉃㄩ 桡搠 桩獴潮
chaperone  activity,  while  variants  consisting  only  of  the  C-terminal  PPIase  domain ⡏丩
or  a  short  N-terminal  domain ⢁ꉃ㈺ ㄭㄲ㌠ 牥獩摵敳   did  not  (Fig.  10f).  These  data
indicate  that  the  PPIase  domain  is not  required  for  the  histone  chaperone  activity  of
SpFkbp30p  and  that  the  N-terminal  domain  is  sufficient  for  this  activity.  These
observations  are  wholly  consistent  with  the  effect  of the  PPIase  inhibitor  (Fig.  10c).
Thus,  nuclear  FKBP  is a dual-function  protein  that bears  histone  chaperone  activity  and
㐱PPIase  activity.  Taken  together,  we  conclude  that  nuclear  FKBP  is  a  novel  histone
chaperone  in vitro.
Other  histone  chaperones  that  have  been  analyzed  (for  example,  nucleoplasmin
(20), N1/N2  (28), NAP-I  (26), TAF-I (29), CAF-I  (30) and ASF 1/CIA (31-34))  have not
been  found  to  contain  enzymatic  domains.  Thus,  nuclear  FKBP  is  the  first  histone
chaperone  found  that  possesses  a  distinct  enzymatic  domain.  Although  a  PPIase
inhibitor  does  not  affect  the  in vitro  nucleosome  assembly  mediated  by  nuclear  FKBP
(Fig.  10c), we  did find  evidence  (described  below)  that indicates  that the PPIase  domain
functions  in vivo in chromatin  organization.
2.3.4  Histone  chaperone  activity  is conserved
Next,  we  investigated  the  role  that  nuclear  FKBP  plays  in chromatin  organization  in
vivo.  To  this  end,  we  took  advantage  of  the  well-established  genetic  system  of  S.
cerevisiae.  SpFkbp39p  and  its  budding  yeast  counterpart,  Fpr435,  have  highly
homologous  primary  structures  (Fig.  11a).  We  first  assessed  the  in  vitro  histone
chaperone  activities  of Fpr4p  and  observed  that it has the same  activity  as the S. pombe
ortholog  (Fig.  11b, c). The N-terminal  domain  of Fpr4p  is necessary  and  sufficient  for
histone  chaperone  activity  (Fig.  11c),  which  indicates  that  functional  domain
localization  and,  more  importantly,  histone  chaperone  activities  are  evolutionarily
conserved  among  the  nuclear  FKBPs.  The  wild  type  (WT)  Fpr4p  has  weaker  histone
㐲chaperone  activity  than  the  N-terminal  domain  alone,  which  indicates  that  C-terminal
regions  of the  full-length  protein  may  exert  an  inhibitory  effect.  However,  the  PPIase
inhibitor  FK506  does not affect  its in vitro  histone  chaperone  activity  (Fig.  11d), which
indicates  the conserved  domain-independency  of SpFkbp39p  and Fpr4p.
2.3.5  Enrichment  of nuclear  FKBP  at  the  nucleolus
We reported  previously  that  SpFkbp39p  is localized  in the  nucleus8.  To analyze  the  in
vivo  function  of  Fpr4p,  we  first  had  to  determine  its  cellular  localizaton.  Thus,  we
performed  an  immunofluorescent  assay  using  laser  scanning  microscopy,  which
revealed  that  Fpr4p  localizes  in  the  nucleus  (Fig.  12a).  This  demonstrates  that  the
cellular  localization  of this  protein  is  conserved  between  S. pombe  and  S.  cerevisiae.
Interestingly,  we  found  that  Fpr4p  is  enriched  in  the  nuclear  subdomain  (Fig.  12a),
which  is where  Sir2p  also  localizes  (shown  as  arrows  in Fig.  5a,  yellow  spots  in the
merged  image  indicate  co-localization  of  the  two  proteins).  Since  Sir2p  has  been
reported  to  localize  predominantly  at  the  nucleolus  in  interphase  (36),  we  speculated
that Fpr4p  also  mainly  localizes  at the  nucleolus.  Confirming  the  nucleolar  localization
of Fpr4p  is that  we found  that  DNA  was extensively  reduced  at the co-localization  area
(indicated  as  arrows  in Fig.  12a, DNA)  because  abundant  rRNA  is known  to displace
DNA  in the nucleolus.  Therefore,  we conclude  that Fpr4p  is localized  in the nucleus  and
is enriched  in the nucleolus.
㐳To  investigate  the  in  vivo  role  that  the  histone  chaperone  domain ⡆灲㒁ꉃ⤠ 潦
nuclear  FKBP  plays,  it  is  necessary  to  make  sure  that  it  localizes  as  well  as  the  full
length  Fpr4p.  Thus,  we  next  tested  the  localization  of  the 䙰爴膢   protein.  The  data
showed  that the histone  chaperone  domain  protein  of Fpr4p  also  localizes  at the nucleus
and  is  enriched  at  the  nucleolus  (Fig.  12b).  This  indicates  that  the  histone  chaperone
domain  is  sufficient  for  the  appropriate  localization  of  the  protein.  From  these
observations,  we predicted  that Fpr4p  may  act  at the rDNA  loci that  form the nucleolus,
and  thus  we  next  investigated  whether  Fpr4p  associates  with  the  chromatin  and  is
enriched  at the rDNA  loci.
2.3.6  Association  of  FKBP  with  rDNA  chromatin
The  nucleolus  contains  100-200  repeats  of  rDNA  genes  that  form  the  condensed
heterochromatin.  To  assess  the  association  of  Fpr4p  with  chromatin  at  rDNA  loci  in
vivo,  we  performed  the  chromatin  immunoprecipitation  (ChIP)  assay  (36).  First  we
constructed  a  strain  that  expresses  a  Flag-tagged  Fpr4p  protein  from  its  native
chromosomal  locus (Fig.  13a) and then  used an anti-Flag  antibody  to immunoprecipitate
the  Fpr4p-associated  DNA.  In this  strain,  the  Flag-tagged  Fpr4p  protein  is specifically
recognized  by  the  anti-Flag  antibody  (Fig.  13b).  We  observed  Flag-tag-dependent
precipitation  of  genes  at  the  rDNA  loci,  which  indicates  that  Fpr4p  associates  with
chromatin  at  the  rDNA  loci  (Fig.  13c).  In contrast,  the  anti-Flag  antibody  precipitated
㐴the DNA at telomeric  regions  and the ACT1  locus two to four times  less efficiently  (Fig.
13c). This  indicates  that  Fpr4p  is enriched  at the rDNA  loci. This  is the first time  that it
has been  shown  that a PPIase  associates  with specific  chromatin  areas  in vivo.
2.3.7  Nuclear  FKBP  is  required  for  silencing
Fpr4p  associates  with  chromatin  at  the  rDNA  loci,  which  are  subjected  to  partial  gene
silencing  that  involves  the  assembly  of heterochromatin.  Thus,  we  reasoned  that  Fpr4p
may  participate  in  the  silencing  of  the  rDNA  locus.  To  address  this  possibility,  we
generated  an fpr4  null mutation  in the  strain  JS237,  in which  the reporter  gene  MET 15
integrated  at the rDNA  locus is partially  silenced  (37). Changes  in the silencing  status of
the  rDNA  locus  can  be  estimated  by  measuring  the  level  of  MET 15 transcription  by
reverse  transcription  (RT)-PCR  analysis.  MET 15 expression  was dramatically  increased
楮 瑨攠 膢晰爴   cells  compared  to  wild  type  cells  (Fig.  14a,  b),  while  ADH1  (negative
control)  was  expressed  at  similar  levels  in both  cell  types.  This  shows  that  deletion  of
FPR4  induces  a  loss  of  silencing  and  indicates  that  endogenous  nuclear  FKBP  is
required  for silencing  at the rDNA  locus.  This provides  the  first evidence  for an in vivo
functional  role  for  endogenous  nuclear  FKBP,  as no  phenotype  had  been  previously
found  for FKBP null mutants  (38).
㐵2.3.8  Histone  chaperone  domain  is sufficient
Since  the  N-terminal  domain  of nuclear  FKBP  has  in vitro  histone  chaperone  activity,
we  next  investigated  its  involvement  in  rDNA  silencing  in  vivo.  We monitored  the
rDNA  silencing  activity  in  Afpr4 cells that  expressed  truncated  versions  of Fpr4p  from
the  FPR4 promoter  on a single  copy plasmid  (Fig.  14c, d).  Expression  of the full length
Fpr4p  (WT)  reduced  the  expression  of MET15  integrated  at  the rDNA  locus  compared
to  vector  alone  (-)  (Fig.  14c,  d),  which  indicates  that  it  complements  the  loss  of
獩汥湣楮朠 楮 膢晰爴   cells.  Expression  of  the  Fpr4p  histone  chaperone  domain ⢁ꉃ⤠ 慬潮
also reduced  the expression  of the MET 15 gene  at the rDNA  loci (Fig.  14c, d). However,
these  effects  were  not  observed  in  cells  expressing  the  PPIase  domain ⢁ꉎ⤠ ⡆楧⸱㑣Ⱐ 搩
Quantitative  real  time  PCR  analysis  further  demonstrated  the  statistically  significant
rDNA  silencing  mediated  by  the  Fpr4p  histone  chaperone  domain  (Table  1).  Thus,
expression  of the histone  chaperone  domain  can  suppress  the  loss of rDNA  silencing  in
the  fpr4  deletion.  The  histone  chaperone  domain  of  nuclear  FKBP  localizes  at  the
nucleus  and  is enriched  at the  nucleolus.  These  results  support  a model  in which  Fpr4p
maintains  silencing  at the rDNA  locus through  its N-terminal  histone  chaperone  domain.
Notably,  however,  the  N-terminal  histone  chaperone  domain  silences  less  than  the  full
length  Fpr4p  (Table  1), which  suggests  that  the  C-terminal  PPIase  domain  plays  some
role in rDNA  silencing  in vivo.
2.3.9  Nuclear  FKBPs  modulate  chromatin  structure  in  vivo
㐶Since  gene  silencing  is affected  by  chromatin  structure,  we  next  investigated  whether
endogenous  nuclear  FKBPs  participate  in  altering  chromatin  structure  at  the  rDNA
locus  by  using  the  indirect  end-labeling  assay.  Here,  yeast  nuclei  were  isolated  and
treated  with  increasing  amounts  of micrococcal  nuclease  (MNase)  to digest  linker  DNA
between  nucleosomes,  and  the  extracted  DNA  was  analyzed  by  Southern  blot
hybridization  using  a  rDNA  probe  comprised  of  non-transcribed  spacer  (NTS)
sequences  from  the  DNA  locus  (40).  If the  conformation  of  chromatin  is changed  at
specific  sites,  we  expect  to  observe  alterations  in  the  MNase-sensitivity  of  the  NTS
sites.
The  MNase  cleavage  pattern  of 膢晰爴 捨牯浡瑩   differed  from  that  of  the  WT  at
the  rDNA  locus  (Fig.  15a).  As  seen  in  lanes  1-4 relative  to lanes  5-8,  the  NTS 1 sites
indicated  by  closed  arrows  were  cleaved  by  MNase  more  efficiently  in膢晰爴 捨牯浡瑩
than  in WT chromatin  (Fig.  15a). The sites indicated  by  open arrows  in莢晰爴 捨牯浡瑩
were  cleaved  less  efficiently  (Fig.  15a).  These  differences  were  not  observed  in  the
NTS2  region  (Fig.  15b)  and  the  amounts  of  total  DNA  were  same  (Fig.  15c), which
indicates  the specific  alteration  of MNase-sensitivity.  These data  indicate  that the rDNA
chromatin  structure  in 膢晰爴 捥汬   differs  from  that  in  WT  cells.  This  result  represents
the  first  demonstration  that  endogenous  PPIase  affects  chromatin  structure  in  vivo.  This
notion  is  consistent  with  the  finding  that 膢晰爴 湵汬   mutations  affect  silencing  at  the
rDNA  locus.  Thus,  endogenous  nuclear  FKBPs  appear  to  participate  in  regulating
silencing  by  associating  with  chromatin  and  altering  the  chromatin  structure  at  the
rDNA  locus  in vivo.
㐷The  data  described  above  indicate  that  while  Fpr4p  associates  with  chromatin  at
both  NTS1  and  NTS2  regions  as  shown  by  the  ChIP  experiment  (Fig.  13),  FPR4-
dependent  alteration  of  chromatin  structure  is  observed  only  at  the  NTS1  region  (Fig.
15).  The  NTS1  region  is  known  to  include  enhancer  activity,  and  SIR2-dependent
alteration  of chromatin  structure  has  also  been  reported  at the NTS1  region  but not the
NTS2  region  (40).  Fpr4p  exists  at  the  NTS2  region  but  its  disruption  does  not  alter
chromatin  structure  there.  It may  be  that  other  molecule (s)  participate  in  altering  the
chromatin  structure  in the NTS2  region.
2.3.10  The  in  vivo  role  played  by  PPIase  domain
In  addition  to  the  demonstrated  requirement  for  the  N-terminal  histone  chaperone
domain,  we  postulate  that  the  C-terminal  PPIase  domain/activity  also  plays  a  non-
essential  regulatory  role  in rDNA  silencing  in  vivo.  To  investigate  this,  we  generated
point  mutations  of evolutionarily  conserved  amino  acids  in the PPIase  domain  that have
been  reported  to  affect  substrate  binding  and  PPIase  activity  (39)  (summarized  in Fig.
16a, Table  2).  The  substitution  of phenylalanine  323  with  tyrosine  (F323Y)  has  been
reported  to  have  the  strongest  effect  on  PPIase  activity  (an  approximately  four-fold
reduction),  while  substitution  of aspartic  acid  324  with  valine  (D324V)  did  not affect
PPIase  activity  in a protein  substrate  assay (39)  (Table 2).
We found  that  the  FPR4  F323Y  mutation  stimulated  rDNA  silencing  while  the
㐸D324V  mutation  did not (Fig.  16b).  Furthermore,  the  substitution  of phenylalanine  323
with  alanine  (F323A)  also  stimulated  silencing,  which  confirms  the  importance  of the
FPR4  phenylalanine  323  side chain  in rDNA  silencing  (Fig.  16b).  Quantitative  analysis
using  another  set of primers  designed  for  real  time  PCR  demonstrated  the  statistically
significant  enhancing  effect  of  the  Phe323  mutations  (Table  2).  These  results  suggest
that  nuclear  FKBP  may  regulate  rDNA  silencing  through  the  PPIase  activity  or pocket.
Since  all  the  purified  point  mutated  nuclear  FKBP  proteins  (Fig.  16c) possess  in vitro
histone  chaperone  activities  that  are  as  good  as  wild  type  activities  (Fig.  16d),  we
speculate  that  endogenous  proteins  and/or  ligands  other  than  histones  may  interact  with
the  PPIase  pocket/domain  of  nuclear  FKBP  and  thereby  mediate  signals  that  are
relevant  to silencing.  Taken together,  these  findings  indicate  that nuclear  FKBP  consists
of  two  separate  domains:  the  histone  chaperone  domain  that  is  essential  for  rDNA
silencing  and  the  PPIase  domain  that  regulates  the  latter  property  (Fig.  17).  The
existence  of these  two  functionally  distinct  domains  is a novel property  for  a chromatin
factor.
㐹2.4  Discussion
2.4.1  Significance  of nuclear  FKBP
PPIases  have  not  previously  been  considered  to  participate  in  altering  nucleosome
structure.  We show  here that  1) nuclear  FKBP  has  in vitro  histone  chaperone  activity  at
stoichiometrically  relevant  concentrations,  2) the  histone  chaperone  activity  of nuclear
FKBP  depends  on  its N-terminal  domain  and is independent  of PPIase  activity  of the C-
terminal  domain,  3) nuclear  FKBP associates  with  chromatin  at rDNA  loci and plays  an
in  vivo  functional  role  in  rDNA  silencing,  as  demonstrated  by  ChIP,  mutation  and
suppression  analyses,  and  4)  the  C-terminal  PPIase  domain  of  nuclear  FKBP  is  not
essential  for  the  silencing  and  histone  chaperone  activity  of the protein  but it regulates
rDNA  silencing  in  vivo.  These  results  provide  the  first  evidence  that  endogenous
nuclear  FKBP  participates  in rDNA  silencing  through  the histone  chaperone  domain  that
we  identified  (Fig.  17).
We found  significant  differences  in the  primary  structures  of nuclear  FKBP  and
classical  histone  chaperones.  The  histone  chaperone  domain  of  nuclear  FKBP  has  a
basic  region  that  is  not  present  in  other  histone  chaperones  (Fig.  8)  and  which  is
assumed  to  interact  with  acidic  molecules  such  as  DNA  and  the  acidic  domains  of
nuclear  proteins.  Furthermore,  we  have  shown  that  there  are  differences  in  the
nucleosome  assembly  reactions  mediated  by  nuclear  FKBP  and  the  classical  histone
chaperone  NAP-I  (Fig.  9).  Taken  together,  we  postulate  that  the  nucleosome
assembly/disassembly  reactions  carried  out by  PPIase  differ  mechanistically  from those
㔰of other  classical  histone  chaperones.
The nucleosome  assembly/disassembly  reactions  mediated  by histone  chaperones
can  be broken  down  into  several  steps:  association  and  dissociation  of histones  H3/H4
with  and  from  DNA,  association  and  dissociation  of histones  H2A/H2B  with  and  from
histones  H3/H4,  association  and removal  of histones  with and  from DNA, and  so on (2).
Thus,  the functional  differences  between  PPIase  and classical  histone  chaperones  can be
resolved  by  identifying  the  step(s)  of nucleosome  assembly/disassembly  reactions  that
they  affect  and the other  chromatin  factors  with which  they  cooperate  at each step.
2.4.2  Nuclear  FKBP  in silencing
In  addition  to  the  nuclear  FKBP  reported  here,  other  histone  chaperones,  including
ASF 1/CIA and  CAF-I,  also  contribute  to  silencing  at the rDNA  locus  (30,41).  The way
in which  distinct  histone  chaperones  relate  to each other  must be understood  in order to
determine  why  different  types  of histone  chaperones  function  in silencing  at the rDNA
locus,  as the cooperative  activity  between  different  classical  histone  chaperones  may  be
important.  For example,  although  ASF 1/CIA and  CAF-I  bind  to different  regions  of the
histone  cores,  they  have  similar  histone  chaperone  activities  and  work  cooperatively  in
DNA  replication  reactions  in  vitro  (31).  Clearly,  the  putative  functional  interactions
between  classical  histone  chaperones  and PPlases  warrants  additional  investigation.
Fpr4  is required  for  the silencing  of a reporter  gene  integrated  at the rDNA  locus
51(Fig.  15),  and  the  point  mutations  that  impair  the  PPIase  activity  of  Fpr4  appear  to
enhance  the  silencing  of the  reporter  gene  at the rDNA  locus  in vivo  (Fig.  16 and  Table
2).  The  null  mutant  of the  nuclear  FKBP  is a  loss  of function  mutant  and  these  point
mutants  should  be considered  as gain  of function  mutants.  Such cases  are well  known  in
the  genetics  in  various  organisms  (for  example,  p53  in mammals  (42)).  These  results
suggest  that  a putative  endogenous  factor  interacts  with  the  C-terminal  PPIase  domain.
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known  to  be  induced  by  mutations  in  several  chromatin  factors  such  as the  silencing
factor  Sir4  and  the  NAD-dependent  histone  deacetylase  Sir2  (36).  Furthermore,  we
捯湦楲浥搠 瑨慴 荪晰爴 桡猠 慬瑥牥搠 獥湳楴楶楴礠 瑯 䵎慳攠 摩来獴楯渠 楮 瑨攠 乔匠 慴 瑨
牄乁 汯捵猠 ⡤慴愠 湯琠 獨潷温⸠ 卩浩污牬礬 瑨攠 膢獩爲 浵瑡湴 慬獯 桡猠 楮捲敡獥搠 獥湳楴楶楴
to  MNase  in  the  NTS  (43).  Therefore,  nuclear  FKBPs  could  interact  with  the  other
chromatin  factors  physically  and/or  functionally  (Fig.  17).  While  nuclear  FKBP
associates  with  chromatin  at  both the  NTS1  and NTS2  regions  (Fig.  13), the  alteration
of chromatin  is dependent  on  Fpr4  only  with  regard  to the NTS1  region  (Fig.  15). This
suggests  that  another  additional  positive  chromatin  factor (s)  is  necessary  for  the
alteration  of  chromatin  structure  at  the  NTS2  region  or  that  a  negative  chromatin
factor (s) must  be  suppressed  before  Fpr4  can function  in this  region.  To understand  the
mechanism  by  which  the  rDNA  locus  is  silenced,  the  functional  relationships  between
the  PPIases  and  the  other  chromatin  factors  must  be  investigated.  For  this,  it  will  be
necessary  to  identify  the  chromatin  factors  that  interact  with  nuclear  FKBP.
522.4.3  PPIase  domains  and  other  domains
We  have  shown  here  that  nuclear  FKBPs  have  dual  functions  consisting  of  histone
chaperone  and  PPIase  activities.  Other  nuclear  PPlases  possess  different  additional
domains.  For  example,  Ess1/Pin1  and  FKBP52  possess  WW  and  Tpr  domains,
respectively,  in addition  to the  PPIase  domain  (44,45),  and these  domains  facilitate  the
identification  of  targets  of  their  PPIase  domains  (42,44-46).  For  example,  the  WW
domain  of  Pin1  interacts  with  mitotic  factors  and  RNA  polymerase  II,  including
phospho-serine/threonine  proline  sequences  (47), and  the Tpr domain  of FKBP52  binds
to molecular  chaperones  such as hsp70  and  hsp9048.  Although  the additional  domain  of
FKBP51  is independent  of the  PPIase  domain  in vitro,  both  domains  are necessary  for
its  full  activity  in  vivo,  as  has  been  demonstrated  for  nuclear  FKBP  (11-13).  These
observations  suggest  a close  relationship  between  PPIase  domains  and  these  additional
domains  with respect  to their  reactions.  This model  is supported  by  our observation  that
the  C-terminal  PPIase  domain  regulates  silencing  in vivo,  while  the N-terminal  histone
chaperone  domain  is essential  for silencing  (Fig.  16).
PPIase  domains  have  been  found  to  catalyze  and/or  interact  with  several
transcription  factors  (7,9-19).  Here,  we  have  shown  that  the  additional  N-terminal
domain  has  histone  chaperone  activity.  Thus,  analogous  to  the  way  in  which
transcriptional  activators  link  DNA  elements  (which  are  the  targets  of  their  DNA-
binding  domains)  to the transcriptional  machinery  (which  is the target  of their  activation
domains),  nuclear  FKBPs  may  bridge  histone-containing  chromatin  complexes  (which
are targets  of the N-terminal  histone  chaperone  domain)  and proline-containing  nuclear
53factors  (which  may  be  targets  for  the  PPIase  domain)  (Fig.  17).  We  propose  that
cooperation  between  the  histone  chaperone  domain/activity  and  the  PPIase
domain/activity  could  efficiently  regulate  chromatin  structure.
2.4.4  Perspectives  for  nuclear  PPIases
The in vitro  MNase  assay  data (Fig.  8e) demonstrate  nucleosome  arrays  up  to only two
nucleosomes.  Similarly,  the  nucleosome  spacing  assembled  by  histone  chaperones  in
vitro  is  not  clearly  ordered  (4,25,32).  Histone  chaperones  assemble  ordered
nucleosomes  together  with  ATPase  (e. g. ACF1)  and  present  a clear  nucleosomal  ladder
in the MNase  assay  in vitro4.  Thus,  we  believe  that nuclear  FKBP  also cooperates  with
ATPase  in  vivo.  Identification  of  the  partner  of  nuclear  FKBP  that  is  involved  in
ordering  the nucleosomes  would  be of interest.
We  postulate  that  nuclear  PPIases  also  participate  in  aspects  of  chromatin
organization  other  than  rDNA  silencing,  because  PPIase  targets  are  present  in various
nuclear  factors.  For  example,  1) several  transcription  and  nuclear  factors  bear  various
types  of  proline-rich  domains,  2)  a  nuclear  PPIase,  human  Pin1,  associates  with  the
proline-rich  carboxyl  terminal  domain  of  a  hyperphosphorylated  form  of the  largest
subunit  of  RNA  polymerase  II  (49,50),  and  3)  Ess1,  a  yeast  homologue  of  Pin1,  is
linked  to  chromatin  remodeling  complexes  and  to  the  general  transcription  machinery
(16,17).  Considering  this  evidence,  we  believe  that  further  analysis  of  nuclear  FKBP
54function  will  considerably  improve  our  understanding  of  the  regulation  of  chromatin
transcription.
55Conclusion
In  the  1st section,  I proposed  a  link  between  the  localization  and  primary  structure
of  FKBPs,  and  provided  evidence  for this  association  by  isolating  and  localizing  a novel
nuclear  FKBP.  I  also  predicted,  on  the  basis  of  its  domain  structure,  that  the  nuclear
FKBP  would  function  towards  DNA  and  histones.
In the  2nd  section,  I provide  evidence  for  other  predictions  raised  in the  1st section.
Nuclear  FKBP  is  a  novel  type  of  histone  chaperone  in  vitro  and  is  involved  in  rDNA
silencing  in  vivo.  Domain  analyses  indicated  that  the  histone  chaperone  domain  of
nuclear  FKBP  is  sufficient  for  rDNA  silencing.  These  analyses  are  the  first
demonstration  of  a  function  for  FKBPs  in  chromatin  organization.  Here,  I  propose  a
concept  whereby  PPIase  is linked  to  the  alteration  of chromatin  structure.
I  was  able  to  identify  this  link  between  FKBP  and  chromatin  by  focusing  on  the
primary  structure  of  FKBPs.  Function  cannot  be  separated  from  structure  and  must  be
related  to  structure.  Thus,  to  investigate  functions  of  unknown  factors,  I  think  it  is
important  to  study  their  primary  structures  in detail.
Perspective
1. Mechanism  of  histone  chaperoning  by  nuclear  FKBP
56The activity of classical histone chaperone is induced by preincubation with histone.
However, nuclear FKBP has activity in the absence of histone.  Thus, I propose that
nuclear  FKBP  has  another  target  other  than  histone.  Given that  the  nucleosome
consists of DNA and histones, I investigated the possibility that nuclear FKBP would
function towards DNA.  Here, I analyze the action of nuclear FKBP on DNA.
The results obtained suggested the existence of two types of histone chaperones.  By
finding  both  commonality  and  variety  among  histone  chaperones,  I  will  further
elucidate the role of histone chaperones in the alteration of chromatin structure.
2. Significance of PPIase  domain
The introduction of point mutations in the PPIase domain of nuclear FKBP enhanced
rDNA silencing.  However, histone chaperone activity was unaffected.  This suggests
that the PPIase domain may act on certain chromatin proteins.
I predict the candidate targets of the PPIase domain as follows:
Histone
As a  major component of  chromatin, histone is a candidate target of the PPIase
domain. However, since point mutation of the PPIase domain does not affect histone
chaperone activity, other targets must exist.  Since PPIase is known to physically
interact with  several chromatin factors, the PPIase domain of nuclear FKBP may
target these chromatin factors.
57Transcriptional  machinery
I  commenced  this  study  because  I had  identified  FKBP  as  a TFIID  interactor.  The
C-terminal  domain  of  the  largest  subunit  of  RNA  polymerase  II  interacts  with  Pin1.
TFIID  alter  its  structure  when  transcription  is  activated.  Thus,  analyses  of  PPIase
in  transcription  may  uncover  novel  mechanisms  of  transcriptional  activation.
DNA-binding  transcriptional  activators
Several  transcriptional  activators  possess  proline-rich  domains,  which  may  be
targets  of  PPIase.
Through  interactions  between  the  PPIase  domain  and  the  factors  described  above,
nuclear  FKBP  may  play  a  role  in  linking  chromatin  to  various  chromatin  factors.
Moreover,  both  histone  chaperone  and  PPIase  domains  can  alter  molecular  structures,
suggesting  that  nuclear  FKBP  could  alter  chromatin  structure  efficiently.
3.  Alteration  of  DNA  structure  by  nuclear  FKBP
Alteration  of  DNA  structure  is  important  in  regulating  access  to  DNA  of  proteins  that
catalyze  gene  expression.  Changes  in  DNA  structure  are  effected  through  enzymes
like  topoisomerases  and  various  DNA-binding  proteins.  Previously,  PPIases  have  been
found  to  participate  in  altering  protein  structures.  Here,  I  found  that  nuclear  FKBPs
also  participate  in  altering  DNA  structure.  Although,  this  data  is  not  included  in  this
thesis,  it  is  summarized  as  follows:
58The  charge  of  the  surface  of  SpFkbp39p  is  basic,  suggesting  that  this  protein
could  bind  to  DNA.  To test this  possibility,  I performed  a DNA  binding  assay  using
DNA-cellulose.  The  results  obtained  indicated  that  SpFkbp39p  and  histones  bound
DNA,  while  CIB protein  did not.  Next,  I investigated  how  SpFkbp39p  could affect  the
structure  of  DNA.  Using  a  supercoiling  assay,  I  tested  the  change  in  the  linking
number  of  circular  DNA  induced  by  SpFkbp39p  in the  absence  of histone  and  in the
presence  of  topoisomerase  I.  The  results  showed  that  SpFkbp39p  decreased  the
amount  of  relaxed  DNA  and  increased  the  amount  of  negatively  supercoiled  DNA
which  had  a linking  number  of one to three  (Fig.  18).  This suggests  that  one molecule
of  circular  DNA  wraps  around  one  to  three  molecules  of  SpFkbp39p.  Next,  I
investigated  the  relationship  between  nucleosome  assembly  activity  and  alteration  of
DNA  structure  by  examining  the  dose-dependent  effects  of  SpFkbp39p  on  these
activities.  Both  activities  increased  in  a  dose-dependent  manner  and  were  correlated
(Figure  19).  Alteration  of DNA  structure  requires  lower  concentrations  of SpFkbp39p
than  for  nucleosome  assembly.  Thus,  the  association  of SpFkbp39p  with  DNA  might
be  a  trigger  for  nucleosome  assembly.  Mediation  of  DNA  structure  alteration  was
observed  only for the full-length,  but not for the N- or C-terminal  portion  of the protein,
indicating  that  the PPIase  domain  is required  for the  alteration  of DNA  structure.  It is
surprising  that  the  PPIase  domain  contributes  to  conformational  changes  not  only  in
protein,  but also  in DNA.
When  chromatin  DNA  is assembled,  many  DNA  binding  proteins  in addition  to
histones  are  included  in the  chromatin  DNA  complex.  Several  DNA  binding  proteins
including  TBP  (TATA box-binding  protein,  a  general  transcription  factor)  and  HMG
59(high  mobility  group,  non-histone  chromatin  component)  have  been  reported  to  prefer
negatively  supercoiled  DNA22  for  their  activities.  SpFkbp39p  might  facilitate  such
factors  by  binding  to chromatin  DNA and altering  DNA structure.
These  in  vitro  observations  demonstrate  that  nuclear  FKBPs  alter  nucleosomal,
DNA  and  protein  structures  (Fig.  20  & 21).  However,  I have  not yet obtained  in vivo
evidence  for  this  phenomenon.  In  my  opinion,  analyses  of  null  mutants  of  nuclear
FKBP  genes  will  indicate  that  endogenous  nuclear  FKBPs  also  participate  in  the
alteration  of DNA structure.
4. Role  of nuclear  FKBP  in silencing  and  aging
Since  histone  deacetylase  SIR2  and  RPD3  are  involved  in  rDNA  silencing,  I
investigated  whether  nuclear  FKBP interacts  with them  genetically  and/or physically.
rDNA  silencing  is closely  related  to aging.  Thus, nuclear  FKBP may  also contribute  to
aging.  Here,  I  will  analyze  functional  interactions  between  nuclear  FKBP  and  the
aging  factors,  SIR2/3/4  and  SGS1,  in  yeast  and  mouse  models.  Furthermore,  I  will
analyze  whether  alteration  of DNA  structure  by nuclear  FKBP is related  to the presence
of extra  chromosomal  DNA,  which  is an aging marker  (Fig. 22).
5. Nuclear  FKBP  and  other  chromatin  factors
60The  catalytic  domain  of SpFkbp39p  is not essential  for  its nucleosome  assembly
activity.  Thus,  I speculated  that  this  catalytic  domain  might  work  cooperatively  with
the N-terminal  region  of SpFkbp39p  and other chromatin  factors.  To investigate  which
factors  contain  acidic  and basic  regions  like  those  of SpFkbp39p,  I searched  for  factors
homologous  to  the  N-terminal  region  of  SpFkbp39p  using  BLAST  and  PSI-BLAST
programs.  Surprisingly,  various  types  of chromatin  factors  were  found  to contain  acidic
and  basic  regions  similar  to those  of  SpFkbp39p  (75  chromatin  factors/238  identified
factors),  for example,  histone  deacetylase,  N-CoR,  the CAF1  p150  subunit,  histone  H1,
topoisomerase,  DNA methylase,  chromodomain  ATPase, centromere  binding  protein  etc.
Although  none  of these  factors  possess  a clear  consensus  motif,  their  common  activity
might  be  mediated  by  the  putative  flexible  structures  present  in their  charged  regions.
In view  of these  considerations,  SpFkbp39p  might  work  on  chromatin  DNA  in tandem
with these  chromatin  factors.  Thus,  I predict  that PPIase  activity  is not required  in the
nucleosome  assembly  reaction  but is needed  to regulate  the  more  complex  organization
of chromatin.
I  found  preliminary  evidence  that  the  PPIase  domain  can  work  on  the  transcriptional
machinery  in  yeast  cells  by  isolating  PPIase  as  a novel  interaction  factor  of  the  general
transcription  factor  TFIID.  From  these  results,  I  propose  that  transcription  factors
and/or  the  transcriptional  machinery  is  associated  with,  and  regulated  by,  PPIase
domains  and  activities,  respectively.
6.  Conservation  of  nuclear  FKBPs.
61Nuclear-type  FKBPs  exist  in  many  species  from  yeast  to  mammals  and  all  have
N-terminal  charged  regions  in  addition  to  PPIase  domains.  Most  of  their  sequences  are
not  highly  conserved,  with  the  exception  of  the  catalytic  domain,  but  interestingly,  they
all  contain  acidic  and  basic  regions  in  their  N-termini,  suggesting  that  the  activities
described  above  might  be  conserved  among  nuclear-type  FKBPs.  In  comparison  to
other  types  of  nuclear  FKBPs,  FKBP25,  a human  nuclear-type  FKBP,  has  a basic  region
but  not  a  typical  acidic  region  in  its  N-terminus.  However,  FKBP25  is  known  to  be
phospholyrated  by  casein  kinase  II,  which  would  increase  its  acidity.  Thus,  in
mammals,  nucleosome  assembly  activity  by  nuclear  FKBP25  might  be  regulated  by
phosphorylation,  perhaps  reflecting  the  complexity  of  differentiation  and  development
in  mammals.
The  Saccharomyces  cerevisiae  homologues  of  SpFkbp39p,  Fpr3  and  Fpr4,  are  not
essential  for  yeast  cell  growth.  I  propose  that  these  FKBPs  may  contribute  to  specific
chromatin  events  because  several  other  chromatin  factors,  such  as  GCN5  and  SWI2,  are
also  not  essential  for  viability  but  are  known  to  regulate  the  expression  of  specific  genes.
In  higher  eukaryotes,  several   PPIases  have  been  reported  to  be  required  for  specific
developmental  stages.  Considering  these  results  and  the  conserved  features  of  their
primary  structures,  I propose  that  the  regulation  of  specific  chromatin  DNA  organization
by  nuclear  PPIases  is  a  common  mechanism  for  diverse  species  from  protozoa  to
metazoa.
Therefore,  to  advance  the  state-of-the-art  on  FKBPs,  I would  like  to  propose  the
following  experiments:
621.  Identification  of  the  targets  molecules  for  FKBPs.  I  plan  to  identify  target  proteins
interacting  with  the  nuclear  FKBPs  using  protein  column  and  two-hybrid  systems.
This  will  indicate  how  nuclear  FKBPs  affect  the  conformation  of  their  target  proteins.
2.  Determining  the  relationship  between  isomerization  of  the  prolyl  imide-bond  and
alteration  of  chromatin  structure.  I  will  investigate  how  isomerization  of  prolyl
imide-bonds  affects  the  alteration  of  chromatin  structure.
3.  The  interactions  of   PPlases  with  transcriptional  machinery.  I  will  also  investigate
how  PPIases  affect  transcriptional  machinery  and  gene  expression.
4.  The  substrates  of  FKBP,  cyclophilin  and  Pin1  are  restricted,  implying  the  existence  of
other  types  of  PPIases.  Thus,  I will  search  for  new  types  of  PPlases.
5.  Finally,  I will  investigate  the  relationship  between  the  rotation  of  the  C  alpha  residue
and  isomerization  of  proline.
Epilogue
It  is  unclear  why  PPIases  exist  in  all  species  and  why  two  types  of  PPIases
(FKBPs  and  cyclophilins)  are not essential  for growth.  Through  the above  analyses,  I
intend  to  resolve  these  issues.  Finally,  my  ultimate  goal  will  be  to  elucidate  the
underlying  basis  of conformational  changes  of proteins  in biological  reactions.
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80Table  1:  The  effects  of  the  nuclear  FKBP  deletion  mutations  on  rDNA  silencing.
Quantitative  RT-PCR  to  measure  levels  of  expression  of  the  MET15  gene  for  rDNA
silencing  Target  mRNAs  from  cells expressing  wild  type  or deletion  mutants  Fpr4p  were
detected  by  quantitative  RT-PCR  of the  total  RNA  prepared  from  each strain.  The results
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deviation  from duplicate  samples).
81Table  2:  The  effects  of  the  nuclear  FKBP  point  mutations  on  rDNA  silencing  and
PPIase  activities.
The  PPIase  activities  of  the  FKBP  mutants  F323Y  and  D324V  have  been  analyzed
previously41.  Quantitative  RT-PCR  to  measure  expression  levels  of the  MET15  gene  for
rDNA  silencing.  Target  mRNAs  from  cells  expressing  wild  type  or point  mutants  Fpr4p
were  detected  by  quantitative  RT-PCR  of the  total  RNA  prepared  from  each strain.  The
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standard  deviation  from duplicate  samples).
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腜㠴腜Figure  1. Nucleotide and deduced amino acid sequences of the cloned Spfkp39+ gene.  Numbers of
nucleotide sequence from the 5'-terminal are shown on the left and amino acid sequence from the N-terminal
on the right.  The arrow at nucleotide position 1525-1665 indicates the position of the DNA fragment we first
obtained by PCR using degenerate oligonucleotide primers. In-frame nonsense codons (TAA) at nucleotide
position 595-597 and 1684-1686 are underlined.  The C terminal region homologous to catalytic domains of
FKBPs is double underlined (at amino acid position 267-361). One basic (at amino acid position 179-265)
and two acidic (positions 58-75 and 124-174) regions are shown underlined and in bold, respectively.
Consensus bipartite nuclear targeting sequences within the basic region are boxed (basic stretch) and dotted-
lined (linker)(at  amino acid positions 184-209 and 215-239).
腜㠵腜Figure  2.  The  interaction  between  SpFkbp39p  and  FK506.  A.  Purity  of  recombinant
SpFKBP39p  protein.  Lane  1,  protein  standard  (kDa);  lane  2,  purified  SpFKBP39p.
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Gel was stained with  Coomassie blue.  B. Binding of  [3H]  dihydro-FK506 to SpFKBP39p.
[3H]  dihydro-FK506  was  incubated  in  the  presence  (circle)  or  the  absence  (square)  of
SpFKBP39p and  fractionated in  LH-20 gel filtration chromatography. [3H]  dihydro-FK506-
bound  fractions  are  eluted  in  void.
腜㠶腜Figure  3.  Peptidyl-prolyl  cis-trans  isomerase  activity  of SpFKBP39p  and  its inhibition  by
FK506.  The absorbance  at time  t was plotted  against time.  Line 1, SpFKBP39p  (52nM);  line 2,
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+FK506;  line 6, enzyme (-)+FK506.
腜㠷腜Figure  4.  Phylogenetic tree analysis of PPIase catalytic domains of eukaryotic  FKBPs.  This
tree is determined by using CLUSTAL W and NJPLOT programs (45) by primary sequences of
PPIase catalytic domains. The symbols N (nucleus), C (cytoplasm) and ER (endoplasmic reticulum)






















鏱鏱鏱腽鏱蹏鏱鏱鏱鏱鏱鏱蹏鏱蹏鏱鏱躱鏱鏱鏱躱鏱苇花荡ꔠ瑱ⵌ荔膡汔昡莂荁钿ꑴ婔楃璂婴䚖ꚁꆃ悑嶁ꆐ呆䩓䩨湲楅块桴Figure  6.  Nuclear localization  of HA-SpFkbp39p.  Strains carrying pREP1, pREP1-HA-
Fkbp39p and pREP1-HA-TBP plasmids were stained with anti-HA antibody. Photographs of
cells showing Nomarski (upper), anti-HA antibody immunofluorescence (middle) and Hoechst





























































䥉⥬Figure  8:  Histone  chaperone  activity  of a nuclear  FKBP  PPIase.
(a)  Comparison  of  the  primary  structures  of  SpFkbp39p  and  NAP-I.  Numbers  indicate  amino  acid
positions.  The  acidic/basic  regions  of  SpFkbp39p  were  originally  described  by  Himukai  et  al.8  (b)
Preparation  of  SpFkbp39p  and  NAP-I  proteins.  Proteins ⠰⸲⺃쩧⤠ 睥牥 慮慬祺敤 批 ㄲ┠ 卄匭
polyacrylamide  gel  electrophoresis  and  stained  with  Coomassie  brilliant  blue.  Lanes  1,  SpFkbp39p;  lane
2,  NAP-I.(c)  Histone  chaperone  activity  as  determined  by  the  supercoiling  assay.  Prior  to  the  assembly
reaction,  SpFkbp39p  or  NAP-I  was  incubated  with  histones  for  1  min  at ㌰膎⸠ 䅦瑥爠 瑨攠 牥慣瑩潮Ⱐ 瑨
DNA  was  extracted  and  analyzed  by  1%  agarose  gel  electrophoresis.  Lanes  1 and  4  show  the  histone
chaperone  activity  of SpFkbp39p  (7 pmol).  Lanes  3 and  6 show reactions  with buffer  alone.  Lanes  2 and
5 show  the  histone  chaperone  activity  of NAP-I  (7 pmol),  which  serves  as a positive  control.  Lanes  1-3,
reactions  in  the  presence  of  core  histones  (4  pmol);  lanes  4-6,  no  core  histones.  R,  relaxed,  and  S,
supercoiled  DNA.(d)  Determination  of the  stoichiometric  relationship  of SpFkbp39p  to core  histones  in
the histone  chaperone  reaction.  Supercoiling  assays were  carried  out with  0, 0.24,  0.48,  0.96,  1.9, 3.9, 7.7
and  15  pmol  (lanes  1-8,  respectively)  SpFkbp39p  and  4 pmol  histones.  R, relaxed,  and  S,  supercoiled
DNA.(e)  Histone  chaperone  activity  as  determined  by  the  micrococcal  nuclease  (MNase)  assay.  The
amounts  of MNase  used were  1.3 U (lanes  1 and  4), 2.5 U (lanes 2 and  5) and  5.0 U (lanes 3 and 6). Lanes
1-3,  a  nucleosome  ladder  detected  in  the  presence  of  SpFkbp39p  (16  pmol);  lanes  4-6,  the  pattern
observed  for  the  control  reaction  with  buffer  alone.  Mono-  and  di-  indicate  mono-  and  di-nucleosomes,
respectively.
腜㤲腜Figure  9:  Difference  between  the  histone  chaperone  reactions  promoted  by  nuclear
FKBP  and  the  classical  histone  chaperone  NAP-I.
(a)  Schematic  depiction  of  the  histone  chaperone  reactions.  Core  histones  and  histone
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by  NAP-I,  but  not  by  SpFkbp39p,  depends  on  prior  incubation  with  histones.  The
supercoiling  assay  was performed  essentially  as described  in Figure 1c.  Lanes  (1, 4,  7,  10),
(2, 5, 8, 11), and  (3, 6, 9,  12) represent  the results  of histone  chaperone  reactions  with buffer
alone,  SpFkbp39p,  and  NAP-I,  respectively.  Lanes  1-6 and  7-12 indicate  reactions  with  (+)
and  without  (-)  prior  incubation  with  histones,  respectively.  Lanes  1-3, 7-9 and  4-6,  10-12
indicate  reactions  in the presence  and  absence  of core histones,  respectively.  R,  relaxed  and
S, supercoiled  DNA.
腜㤳腜Figure  10: The  histone  chaperone  domain  is distinct  from  the  PPIase  domain.
(a)  Comparison  of  the  primary  structures  of  SpFkbp39p  (nucleus-specific  type)  and  FKBP12  (cytosol-
specific  type).  Nuclear  FKBP  has  a  long  N-terminal  domain  in  addition  to  the  PPIase  domain,  while
cytosolic  FKBP12  does not.  Numbers  on  the boxes  indicate  amino  acid positions.  The subdomains  in the
N-terminal  domain  of  SpFkbp39p  are  as described8.(b)  Nuclear  FKBP,  but  not  cytosolic  FKBP,  has
histone  chaperone  activity.  Lanes  (1-3)  and  (4-6)  show reactions  in the presence  and  absence  of histones
(4  pmol),  respectively.  Lanes  (1,  4),(2,  5)  and  (3,  6)  show  control  reactions  with  buffer  alone,
SpFkbp39pb  (nuclear  type;  7 pmol)  and FKBP12  (cytosolic  type;  7 pmol),  respectively.  R, relaxed  and S,
supercoiled  DNA.(c)  Effect  of  the  PPIase  inhibitor  FK506  on  the  histone  chaperone  activity  of
SpFkbp39p.  Lanes  (1-6)  and  (7-10)  show  reactions  in  the  presence  and  absence  of  histones  (4  pmol),
respectively.  Lanes  (1,  2,  7,  8),(3,  4,  9,  10)  and  (5,  6)  show  control  reactions  with  buffer  alone,
SpFkbp39p  (7 pmol)  and NAP-I  (7 pmol),  respectively.  Odd-and  even-numbered  lanes  show reactions  in
the  presence  and  absence  of FK506  (100  pmol),  respectively.  R, relaxed  and  S,  supercoiled  DNA.(d)
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terminal  PPIase,  the N-terminal  (1-123  residues)  and  (1-256 residues)  domains,  respectively.  The number
of amino  acids  in each  segment  is indicated  on  the  box.(e)  Preparation  of WT  and  truncated  proteins.
偲潴敩湳 ⠰⸲菊朩  indicated  in  the  panel  were  analyzed  by  12%  SDS-polyacrylamide  gel  electrophoresis
and  stained  with  Coomassie  brilliant  blue.  Lanes  1,  2,  3  and  4  renresent  the  nurified  WT ₁ꉃㄬ₁ꉃ㈠ 慮
膢丠 灲潴敩湳Ⱐ 牥獰散瑩癣汹Ⱘ昩 Histone  chaperone  activity  of  WT  and  mutant  proteins.  The  supercoiling
assay  was  performed  under  the  same  conditions  as  in  Figure  1c.  Lanes  1,  2,  3,  4  and  5  show  histone
chaperone  reactions  with  buffer  alone,  WT, ₁ꉃㄬ 膢䌲 慮搠 膢丠 灲潴敩湳 ⠷ 灭潬⤬ 牥獰散瑩癥汹⸠ 刬 牥污硥
and  S,  supercoiled  DNA.
腜㤴腜Figure  11:  Conservation  of  the  histone  chaperone  activities  of  nuclear  FKBPs.
(a)  Scheme  of  WT  and  truncated  Fpr4  proteins. ₁ꉎ 慮搠 膢䌠 慲攠 瑨攠 䌭瑥浮楮慩 偐䥡獥 慮搠 瑨攠 中
terminal  domains,  respectively.  The  number  of  amino  acids  in  each  segment  is  indicated  on  the  box.
(b)  Purity  of  WT  and  truncated  Fpr4  proteins.  Proteins ⠰⸲菊朩 睥牥 慮慬祺敤 批 ㄲ┠ 卄匭
polyacrylamide  gels  and  stained  by  Coomassie  brilliant  blue.  Lanes  1, 2  and  3 represent  the  purified
坔ⲁꉃ 慮搠 膢丠 灲潴敩湳Ⱐ 牥獰散瑩癥汹  (c)  Histone  chaperone  activities  are  conserved  between  the  S.
cerevisiae  and  S.  pombe  nuclear  FKBPs.  After  the  nucleosome  assembly  reaction,  DNA  was
extracted  and  analyzed  by  1%  agarose  gel  electrophoresis.  Lanes  1, 2,  3 and  4  show  reactions  with
扵晦敲 慬潮攬 䙰爴 坔ⲁꉃ 慮搠 膢   proteins  (7 pmol),  respectively.  R,  relaxed  and  S,  supercoiled
DNA.(d)  Conserved  effect  of the  PPIase  inhibitor  FK506  on  the  histone  chaperone  activity  by  S.
cerevisiae  nuclear  FKBP.  Lanes 1  and  2 show  reactions  in the presence  and  absence  of histones  (4
pmol),  respectively.  R, relaxed  and  S, supercoiled  DNA.
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